Background
Methods
Statistical methods
Left ventricular dimensions and functions in the adult
CMR acquisition parameters
First author, year | CMR technique | n, male:female | Age range (years) |
---|---|---|---|
Hudsmith, 2005 [22] | 1.5 T, short axis bSSFP, papillary muscles included in LV mass | 63:45 | 21–68 |
Maceira, 2006 [10] | 1.5 T, short axis bSSFP, papillary muscles included in LV mass | 60:60 | 20–80 |
Chang, 2012 [23] | 1.5 T, short axis bSSFP, papillary muscles included in LV volume | 64:60 | 20–70 |
Macedo, 2013 [24] | 1.5 T, short axis bSSFP, papillary muscles included in LV mass | 54:53 | 20–80 |
Yeon, 2015 [25] | 1.5 T, short axis bSSFP, papillary muscles included in LV volume | 512:340 | (61 ± 9)a |
Le, 2016 [11] | 3 T, short axis bSSFP, papillary muscles included in LV mass | 91:89 | 20–69 |
Le Ven, 2016 [14] | 1.5 T, Short axis bSSFP, papillary muscles included in LV mass | 196:238 | 18–36 |
Lei, 2017 [15] | 3 T, short axis bSSFP, papillary muscles included in LV volume | 60:60 | 23–83 |
Petersen, 2017 [16] | 1.5 T, short axis bSSFP, papillary muscles included in LV volume | 368:432 | 45–74 |
Bentatou, 2018 [12] | 1.5 T, short axis bSSFP, papillary muscles included in LV mass | 70:70 | 20–69 |
Buelow, 2018 [13] | 1.5 T, short axis bSSFP, papillary muscles included in LV mass | 291:326 | 20–80b |
Liu, 2018 [26] | 1.5 T, short axis bSSFP, papillary muscles included in LV mass | 50:50 | 20–70 |
CMR analysis methods
Demographic parameters
Parameter | Men | Women | ||||||
---|---|---|---|---|---|---|---|---|
n | Meanp | SDp | LL–ULh | n | Meanp | SDp | LL–ULh | |
LVEDV (ml)a | 464 | 155 | 30 | 95–215 | 485 | 123 | 22 | 78–167 |
LVEDV/BSA (ml/m2)b | 875 | 79 | 15 | 50–108 | 931 | 73 | 12 | 50–96 |
LVESV (ml)a | 464 | 55 | 15 | 25–85 | 485 | 43 | 11 | 21–64 |
LVESV/BSA (ml/m2)b | 875 | 29 | 9 | 11–47 | 931 | 25 | 7 | 10–40 |
LVSV (ml)c | 410 | 103 | 21 | 61–145 | 432 | 83 | 16 | 52–114 |
LVSV/BSA (ml/m2)d | 701 | 52 | 10 | 33–72 | 758 | 49 | 8 | 33–64 |
LVEF (%)b | 875 | 64 | 8 | 49–79 | 931 | 66 | 7 | 52–79 |
LVM (g)a | 464 | 121 | 28 | 66–176 | 485 | 83 | 21 | 41–125 |
LVM/BSA (g/m2)e | 805 | 62 | 11 | 39–85 | 861 | 49 | 10 | 30–68 |
LVCO (l/min)f | 91 | 5.6 | 1.1 | 3.4–7.8 | 89 | 4.5 | 0.9 | 2.7–6.3 |
LVCI (l/min/m2)f | 91 | 3.0 | 0.6 | 1.8–4.2 | 89 | 2.9 | 0.5 | 1.9–3.9 |
LVM/LVEDV (g/ml)g | 287 | 0.7 | 0.1 | 0.4–0.9 | 327 | 0.6 | 0.1 | 0.3–0.8 |
Parameter | 20–29 years | 30–39 years | 40–49 years | 50–59 years | 60–69 years | |||||
---|---|---|---|---|---|---|---|---|---|---|
n | Meanp ± SDp (LL–UL)c | n | Meanp ± SDp (LL–UL)c | n | Meanp ± SDp (LL–UL)c | n | Meanp ± SDp (LL–UL)c | n | Meanp ± SDp (LL–UL)c | |
LVEDV/BSA (ml/m2) | 51a | 86 ± 13 (61–112) | 105a | 81 ± 11 (59–103) | 110a | 83 ± 14 (55–110) | 78a | 77 ± 14 (49–105) | 34 b | 78 ± 11 (57–99) |
LVESV/BSA (ml/m2) | 51a | 34 ± 10 (14–53) | 105a | 30 ± 8 (15–46) | 110a | 32 ± 9 (13–50) | 78a | 29 ± 8 (12–45) | 34 b | 30 ± 8 (13–46) |
LVSV/BSA (ml/m2) | 41b | 54 ± 7 (40–68) | 93b | 51 ± 8 (34–67) | 101b | 52 ± 8 (36–68) | 63b | 49 ± 10 (30–69) | 34 b | 48 ± 8 (34–63) |
LVEF (%) | 51a | 60 ± 7 (46–74) | 105a | 63 ± 7 (49–77) | 110a | 62 ± 7 (48–76) | 78a | 63 ± 7 (49–78) | 34 b | 62 ± 7 (48–76) |
LVM/BSA (g/m2) | 51a | 66 ± 11 (44–87) | 105a | 64 ± 11 (41–86) | 110a | 64 ± 10 (43–84) | 78a | 62 ± 10 (42–83) | 34 b | 62 ± 12 (38–87) |
Parameter | 20–29 years | 30–39 years | 40–49 years | 50–59 years | 60–69 years | |||||
---|---|---|---|---|---|---|---|---|---|---|
n | Meanp ± SDp (LL–UL)c | n | Meanp ± SDp (LL–UL)c | n | Meanp ± SDp (LL–UL)c | n | Meanp ± SDp (LL–UL)c | n | Meanp ± SDp (LL–UL)c | |
LVEDV/BSA (ml/m2) | 43a | 77 ± 12 (54–100) | 110a | 77 ± 13 (52–102) | 127a | 73 ± 12 (50–96) | 93a | 68 ± 10 (48–89) | 41b | 68 ± 8 (51–84) |
LVESV/BSA (ml/m2) | 43a | 29 ± 7 (16–43) | 110a | 29 ± 10 (9–49) | 127a | 27 ± 7 (12–42) | 93a | 24 ± 7 (10–38) | 41b | 25 ± 5 (14–35) |
LVSV/BSA (ml/m2) | 33b | 50 ± 6 (38–63) | 92b | 49 ± 7 (34–64) | 116b | 48 ± 8 (32–64) | 84b | 47 ± 6 (34–59) | 41b | 44 ± 7 (31–58) |
LVEF (%) | 43a | 62 ± 6 (50–73) | 110a | 64 ± 6 (52–77) | 127a | 63 ± 7 (50–76) | 93a | 65 ± 6 (52–78) | 41b | 65 ± 6 (53–77) |
LVM/BSA (g/m2) | 43a | 51 ± 11 (29–72) | 110a | 50 ± 9 (32–68) | 127a | 49 ± 9 (32–66) | 93a | 51 ± 10 (31–70) | 41b | 52 ± 11 (31–74) |
Parameter | Men | Women | ||||||
---|---|---|---|---|---|---|---|---|
n | Meanp | SDp | LL–ULg | n | Meanp | SDp | LL–ULg | |
LVEDV (ml)a | 832 | 145 | 31 | 83–207 | 1064 | 112 | 21 | 70–155 |
LVEDV/BSA (ml/m2)b | 832 | 77 | 15 | 47–107 | 1064 | 69 | 12 | 45–93 |
LVESV (ml)a | 832 | 53 | 18 | 19–88 | 1064 | 39 | 12 | 15–64 |
LVESV/BSA (ml/m2)b | 832 | 29 | 9 | 11–47 | 1064 | 24 | 7 | 10–38 |
LVSV (ml)a | 832 | 91 | 18 | 55–127 | 1064 | 73 | 13 | 47–99 |
LVSV/BSA (ml/m2)c | 772 | 48 | 9 | 30–66 | 1004 | 45 | 7 | 30–59 |
LVEF (%)b | 832 | 63 | 6 | 51–76 | 1064 | 66 | 7 | 52–79 |
LVM (g)a | 832 | 105 | 24 | 57–152 | 1064 | 73 | 15 | 43–103 |
LVM/BSA (g/m2)b | 832 | 56 | 10 | 36–75 | 1064 | 45 | 7 | 30–59 |
LVCO (l/min)d | 464 | 6.1 | 1.1 | 3.9–8.3 | 632 | 4.9 | 1.0 | 3.0–6.9 |
LVCI (l/min/m2)e | 404 | 3.2 | 0.6 | 2.1–4.3 | 572 | 2.9 | 0.5 | 1.9–4.0 |
LVM/LVEDV (g/ml)f | 708 | 0.7 | 0.2 | 0.3–1.2 | 944 | 0.7 | 0.1 | 0.4–1.0 |
Studies included in this review
Additional left ventricular function parameters
Parameter | Men (n = 60) | Women (n = 60) | ||||
---|---|---|---|---|---|---|
Mean | SD | LL–ULa | Mean | SD | LL–ULa | |
PFRE (ml/s) | 527 | 140 | 247–807 | 477 | 146 | 185–769 |
PFRE /BSA (ml/m2) | 270 | 70 | 130–410 | 279 | 81 | 117–441 |
PFRE/EDV (/s) | 3.4 | 0.7 | 2.0–4.8 | 3.8 | 0.8 | 2.2–5.4 |
PFRA (ml/s) | 373 | 82 | 209–537 | 283 | 69 | 145–421 |
PFRA/BSA (ml/m2) | 193 | 44 | 105–281 | 168 | 44 | 80–256 |
PFRA/EDV (/s) | 2.6 | 0.6 | 1.4–3.8 | 2.3 | 0.5 | 1.3–3.3 |
PFRE/PFRA | 1.4 | 0.3 | 0.8–2.0 | 1.7 | 0.3 | 1.1–2.3 |
Septal AVPD (mm) | 15 | 4 | 7–23 | 14 | 3 | 8–20 |
Septal AVPD /long length (%) | 15 | 3 | 9–21 | 16 | 4 | 8–24 |
Lateral AVPD (mm) | 18 | 4 | 10–26 | 17 | 3 | 11–23 |
Lateral AVPD /long length (%) | 17 | 3 | 11–23 | 19 | 3 | 13–25 |
Sphericity index, diastoleb | 0.31 | 0.07 | 0.20–0.48 | 0.34 | 0.07 | 0.20–0.48 |
Sphericity index, systole | 0.20 | 0.05 | 0.1–0.3 | 0.23 | 0.07 | 0.09–0.37 |
Parameter | Men | Women | ||||||
---|---|---|---|---|---|---|---|---|
n | Meanp | SDp | LL–ULe | n | Meanp | SDp | LL–ULe | |
LV end-diastolic diameter 4Ch (mm)a | 227 | 52 | 5 | 42–62 | 188 | 49 | 5 | 39–59 |
LV end-diastolic diameter SAx (mm)b | 400 | 53 | 5 | 44–62 | 572 | 49 | 4 | 41–57 |
LV end-systolic diameter 4Ch (mm)c | 54 | 32 | 3 | 26–38 | 53 | 28 | 6 | 16–40 |
LV end-systolic diameter SAx (mm)d | 60 | 34 | 3 | 28–40 | 60 | 31 | 4 | 23–39 |
Right ventricular dimensions and functions in the adult
CMR acquisition parameters
CMR analysis methods
Demographic parameters
Studies included in this review
First author, year | CMR technique | n, male:female | Age range (years) |
---|---|---|---|
Hudsmith, 2005 [22] | 1.5 T, short axis bSSFP, papillary muscles included in RV volume | 63:45 | 21–68 |
Maceira, 2006 [29] | 1.5 T, short axis bSSFP, papillary muscles included in RV mass | 60:60 | 20–80 |
Chang, 2012 [23] | 1.5 T, short axis bSSFP, papillary muscles included in RV volume | 64:60 | 20–70 |
Macedo, 2013 [24] | 1.5 T, short axis bSSFP, papillary muscles included in RV volume | 54:53 | 20–80 |
Le Ven, 2015 [14] | 1.5 T, short axis bSSFP, papillary muscles included in RV volume | 196:238 | 18–36 |
Lei, 2016 [15] | 3 T, short axis bSSFP, papillary muscles included in RV volume | 60:60 | 23–83 |
Le, 2016 [11] | 3 T, short axis bSSFP, papillary muscles included in RV volume | 91:89 | 20–69 |
Aquaro, 2017 [18] | 1.5 T, short axis bSSFP, papillary muscles included in RV volume | 173:135 | 16– > 60 |
Petersen, 2017 [16] | 1.5 T, short axis bSSFP, papillary muscles included in RV volume | 368:432 | 45–74 |
Parameter | Men (n = 60) | Women (n = 60) | ||||
---|---|---|---|---|---|---|
Mean | SD | LL–ULa | Mean | SD | LL–ULa | |
RVEDV (ml) | 163 | 27 | 109–217 | 127 | 24 | 79–175 |
RVEDV/BSA (ml/m2) | 83 | 13 | 58–109 | 74 | 12 | 51–97 |
RVESV (ml) | 57 | 17 | 23–91 | 44 | 15 | 13–75 |
RVESV/BSA (ml/m2) | 29 | 9 | 12–46 | 26 | 8 | 9–42 |
RVSV (ml) | 106 | 18 | 71–141 | 83 | 13 | 56–110 |
RVSV/BSA (ml/m2) | 54 | 8 | 38–71 | 48 | 7 | 35–61 |
RVEF (%) | 66 | 7 | 51–80 | 66 | 7 | 52–80 |
RVM (g) | 66 | 15 | 37–95 | 48 | 11 | 26–71 |
RVM/BSA (g/m2) | 34 | 7 | 20–48 | 28 | 6 | 16–40 |
Parameter | Men | Women | ||||||
---|---|---|---|---|---|---|---|---|
n | Meanp | SDp | LL–ULg | n | Meanp | SDp | LL–ULg | |
RVEDV (ml)a | 896 | 166 | 39 | 87–244 | 977 | 122 | 27 | 68–176 |
RVEDV/BSA (ml/m2)b | 1069 | 88 | 17 | 53–123 | 1112 | 76 | 14 | 48–104 |
RVESV (ml)a | 896 | 73 | 22 | 29–117 | 977 | 50 | 15 | 20–80 |
RVESV/BSA (ml/m2)b | 1069 | 38 | 11 | 17–59 | 1112 | 30 | 9 | 13–48 |
RVSV (ml)c | 842 | 95 | 26 | 43–146 | 924 | 74 | 18 | 39–109 |
RVSV/BSA (ml/m2)d | 955 | 52 | 12 | 28–75 | 999 | 48 | 9 | 29–66 |
RVEF (%)b | 1069 | 57 | 8 | 42–72 | 1112 | 60 | 7 | 46–74 |
RVM (g)e | 117 | 36 | 9 | 17–54 | 98 | 30 | 9 | 13–48 |
RVM/BSA (g/m2)e | 117 | 19 | 4 | 10–28 | 98 | 17 | 5 | 7–28 |
RVCO (l/min)f | 155 | 5.6 | 1.4 | 2.8–8.3 | 149 | 4.4 | 1.0 | 2.4–6.4 |
RVCI (l/min/m2)f | 155 | 3.0 | 0.7 | 1.5–4.5 | 149 | 2.8 | 0.6 | 1.6–4.0 |
Parameter | 20–29 years | 30–39 years | 40–49 years | 50–59 years | ||||
---|---|---|---|---|---|---|---|---|
n | Meanp ± SDp (LL–UL)c | n | Meanp ± SDp (LL–UL)c | n | Meanp ± SDp (LL–UL)c | n | Meanp ± SDp (LL–UL)* | |
RVEDV/BSA (ml/m2)a | 50 | 94 ± 15 (63–124) | 55 | 83 ± 13 (57–109) | 49 | 81 ± 16 (50–112) | 55 | 80 ± 16 (48–111) |
RVESV/BSA (ml/m2)a | 50 | 44 ± 11 (23–66) | 55 | 38 ± 8 (22–53) | 49 | 34 ± 8 (18–49) | 55 | 35 ± 10 (16–54) |
RVSV/BSA (ml/m2)b | 40 | 51 ± 13 (26–77) | 43 | 46 ± 10 (27–65) | 40 | 44 ± 11 (23–65) | 40 | 51 ± 13 (24–78) |
RVEF (%)a | 50 | 52 ± 8 (36–69) | 55 | 55 ± 7 (41–68) | 49 | 57 ± 8 (40–73) | 55 | 57 ± 8 (41–74) |
Parameter | 20–29 years | 30–39 years | 40–49 years | 50–59 years | ||||
---|---|---|---|---|---|---|---|---|
n | Meanp ± SDp (LL–UL)c | n | Meanp ± SDp (LL–UL)c | n | Meanp ± SDp (LL–UL)c | n | Meanp ± SDp (LL–UL)* | |
RVEDV/BSA (ml/m2) a | 47 | 78 ± 12 (55–101) | 51 | 76 ± 12 (51–100) | 46 | 74 ± 14 (46–102) | 46 | 69 ± 13 (42–95) |
RVESV/BSA (ml/m2) a | 47 | 33 ± 12 (10–56) | 51 | 31 ± 8 (15–48) | 46 | 29 ± 8 (13–45) | 46 | 28 ± 8 (11–44) |
RVSV/BSA (ml/m2)b | 37 | 46 ± 9 (28–63) | 33 | 45 ± 12 (22–69) | 35 | 47 ± 11 (24–69) | 37 | 42 ± 10 (22–62) |
RVEF (%)a | 47 | 56 ± 11 (34–78) | 51 | 58 ± 9 (39–77) | 46 | 60 ± 8 (44–76) | 46 | 61 ± 8 (44–78) |
Additional RV function parameters
Left atrial dimensions and functions in the adult
CMR acquisition parameters
CMR analysis methods
Demographic parameters
Studies included in this review
First author, year | CMR technique | n, male:female | Age range (years) |
---|---|---|---|
Sievers, 2005 [35] | 1.5 T, 2, 3 and 4 chamber bSSFP; measurement of diameters | 59:52 | 25–73 |
Maceira, 2010 [31] | 1.5 T, short axis, 2, 3 and 4 chamber bSSFP; 3D modeling and measurement of area and diameters; atrial appendage included, pulmonary veins excluded (for volume analysis) | 60:60 | 20–80 |
Le, 2016 [11] | 3 T, 2 and 4 chamber bSSFP; quantification of volume; biplane area-length method; atrial appendage and pulmonary veins excluded | 91:89 | 20–69 |
Le Ven, 2016 [14] | 1.5 T, short axis bSSFP; quantification of volume and function; Simpson’s method; atrial appendage included, pulmonary veins excluded | 195:239 | 18–36 |
Aquaro, 2017 [18] | 1.5 T, 4 chamber bSSFP; measurement of area | 173:135 | 16– > 60 |
Li, 2017 [33] | 3 T, short axis, 2, 3 and 4 chamber bSSFP; measurement of volume, function (biplane area-length and Simpson’s method atrial appendage excluded) and diameter | 66:69 | 23–83 |
Petersen, 2017 [16] | 1.5 T, 2 and 4 chamber bSSFP; quantification of volume and function; biplane area-length method; atrial appendage and pulmonary veins excluded | 371:433 | 45–74 |
Zemrak, 2017 [34] | 1.5 T, 2 and 4 chamber bSSFP; quantification of volume; biplane area-length method; atrial appendage and pulmonary veins excluded | 109:174 | (65 ± 9)a |
Funk, 2018 [32] | 1.5 T and 3 T, 2 and 4 chamber bSSFP; quantification of volume and function; biplane area-length method; atrial appendage and pulmonary veins excluded | 105:77 | 19–76 |
Method | Parameter | Men | Women | ||||||
---|---|---|---|---|---|---|---|---|---|
n | Meanp | SDp | LL–ULj | n | Meanp | SDp | LL–ULj | ||
Biplane area-length method; LA appendage excluded | Max. LA volume (ml)a | 734 | 72 | 20 | 31–112 | 841 | 64 | 18 | 28–100 |
Max. LA volume/BSA (ml/m2)a | 734 | 38 | 11 | 17–59 | 841 | 39 | 11 | 17–61 | |
Min. LA volume (ml)b | 171 | 25 | 10 | 6–44 | 146 | 22 | 8 | 7–38 | |
Min. LA volume/BSA (ml/m2)c | 171 | 14 | 5 | 3–24 | 146 | 13 | 5 | 4–23 | |
LA stroke volume (ml)d | 468 | 44 | 12 | 21–67 | 509 | 42 | 10 | 21–62 | |
LA stroke volume/BSA (ml/m2)e | 363 | 22 | 6 | 10–34 | 432 | 22 | 6 | 10–34 | |
LA ejection fraction (%)f | 534 | 62 | 8 | 46–77 | 578 | 63 | 8 | 48–78 | |
Simpson’s method; LA appendage excluded | Max. LA volume (ml)g | 66 | 70 | 15 | 40–99 | 69 | 66 | 13 | 39–93 |
Max. LA volume/BSA (ml/m2)g | 66 | 41 | 8 | 24–57 | 69 | 44 | 8 | 28–60 | |
Min. LA volume (ml)g | 66 | 32 | 9 | 15–50 | 69 | 28 | 7 | 15–42 | |
Min. LA volume/BSA (ml/m2)g | 66 | 19 | 5 | 9–28 | 69 | 19 | 4 | 11–27 | |
LA ejection fraction (%)g | 66 | 54 | 8 | 38–70 | 69 | 57 | 6 | 45–69 | |
Simpson’s method; LA appendage included | Max. LA volume (ml)h | 256 | 78 | 18 | 42–115 | 298 | 66 | 14 | 37–94 |
Max. LA volume/BSA (ml/m2)h | 256 | 40 | 8 | 25–56 | 298 | 39 | 7 | 25–53 | |
Min. LA volume (ml)i | 196 | 32 | 9 | 14–50 | 238 | 24 | 7 | 10–38 | |
Min. LA volume/BSA (ml/m2)i | 196 | 17 | 4 | 9–25 | 238 | 15 | 4 | 7–23 | |
LA stroke volume (ml)i | 196 | 47 | 13 | 21–73 | 238 | 39 | 10 | 19–59 | |
LA stroke volume/BSA (ml/m2)i | 196 | 24 | 6 | 12–36 | 238 | 24 | 5 | 14–34 | |
LA ejection fraction (%)i | 196 | 59 | 8 | 43–75 | 238 | 61 | 7 | 47–75 |
Parameter | Men | Women | ||||||
---|---|---|---|---|---|---|---|---|
n | Meanp | SDp | LL–ULf | n | Meanp | SDp | LL–ULf | |
Max. LA area 2Ch (cm2)a | 60 | 21 | 5 | 12–30 | 60 | 19 | 5 | 10–28 |
Max. LA area 2Ch/BSA (cm2/m2)a | 60 | 11 | 2 | 6–16 | 60 | 11 | 2 | 6–16 |
Max. LA area 3Ch (cm2)a | 60 | 19 | 4 | 12–26 | 60 | 17 | 4 | 10–24 |
Max. LA area 3Ch/BSA (cm2/m2)a | 60 | 10 | 2 | 6–14 | 60 | 10 | 2 | 6–14 |
Max. LA area 4Ch (cm2)b | 233 | 23 | 5 | 13–32 | 173 | 21 | 4 | 13–29 |
Max. LA area 4Ch/BSA (cm2/m2)b | 233 | 12 | 2 | 7–16 | 195 | 12 | 2 | 8–15 |
Max. LA longitudinal diameter 2Ch (cm)c | 185 | 4.9 | 0.7 | 3.5–6.2 | 181 | 4.6 | 0.7 | 3.3–5.9 |
Max. LA longitudinal diameter 2Ch/BSA (cm/m2)c | 185 | 2.6 | 0.5 | 1.6–3.6 | 181 | 2.8 | 0.6 | 1.6–3.9 |
Max. LA transverse diameter 2Ch (cm)d | 126 | 4.4 | 0.6 | 3.2–5.6 | 129 | 4.3 | 0.5 | 3.3–5.2 |
Max. LA transverse diameter 2Ch/BSA (cm/m2)d | 126 | 2.4 | 0.3 | 1.7–3.0 | 129 | 2.7 | 0.3 | 2.2–3.2 |
Max. LA longitudinal diameter 3Ch (cm)e | 66 | 5.5 | 0.6 | 4.2–6.8 | 69 | 5.4 | 0.7 | 4.0–6.7 |
Max. LA longitudinal diameter 3Ch/BSA (cm/m2)e | 66 | 3.2 | 0.4 | 2.4–4.0 | 69 | 3.6 | 0.5 | 2.7–4.6 |
Max. LA antero-posterior diameter 3Ch (cm)c | 185 | 3.0 | 0.5 | 2.0–4.0 | 181 | 3.0 | 0.5 | 2.0–4.0 |
Max. LA antero-posterior diameter 3Ch/BSA (cm/m2)c | 185 | 1.6 | 0.3 | 1.0–2.2 | 181 | 1.8 | 0.4 | 1.1–2.5 |
Max. LA longitudinal diameter 4Ch (cm)d | 126 | 5.8 | 0.6 | 4.6–7.1 | 129 | 5.5 | 0.6 | 4.2–6.8 |
Max. LA longitudinal diameter 4Ch/BSA (cm/m2)d | 126 | 3.2 | 0.4 | 2.3–4.1 | 129 | 3.5 | 0.5 | 2.5–4.4 |
Max. LA transverse diameter 4Ch (cm)c | 185 | 4.3 | 0.5 | 3.3–5.3 | 181 | 4.1 | 0.5 | 3.1–5.1 |
Max. LA transverse diameter 4Ch/BSA (cm/m2)c | 185 | 2.2 | 0.3 | 1.6–2.9 | 181 | 2.5 | 0.4 | 1.8–3.2 |
Right atrial dimensions and functions in the adult
CMR acquisition parameters
CMR analysis methods
Demographic parameters
Studies included in this review
First author, year | CMR technique | n, male:female | Age range (years) |
---|---|---|---|
Maceira, 2013 [37] | 1.5 T, short axis, RV 2 chamber and 4 chamber bSSFP, 3D modeling and measurement of area and diameters, atrial appendage included for volume analysis | 60:60 | 20–80 |
Le Ven, 2015 [14] | 1.5 T, short axis bSSFP, quantification of volume and function (Simpson’s method), atrial appendage included | 196:238 | 25–73 |
Le, 2016 [11] | 3.0 T, 4 chamber bSSFP, measurement of area | 91:89 | 20–69 |
Aquaro, 2017 [18] | 1.5 T, 4 chamber bSSFP, measurement of area | 173:135 | 16– > 60 |
Li, 2017 [33] | 3.0 T, Short axis, RV 2 chamber and 4 chamber bSSFP, measurement of diameter, volume and function (biplane area-length and Simpson’s method), atrial appendage excluded | 66:69 | 23–83 |
Method | Parameter | Men | Women | ||||||
---|---|---|---|---|---|---|---|---|---|
N | Meanp | SDp | LL–ULd | n | Meanp | SDp | LL–ULd | ||
Biplane area-length method; RA appendage excluded | Max. RA volume (ml)a | 66 | 65 | 20 | 24–105 | 69 | 53 | 14 | 24–81 |
Max. RA volume/BSA (ml/m2)a | 66 | 38 | 12 | 15–61 | 69 | 35 | 10 | 16–54 | |
Min. RA volume (ml)a | 66 | 32 | 12 | 9–55 | 69 | 23 | 7 | 9–37 | |
Min. RA volume/BSA (ml/m2)a | 66 | 19 | 7 | 5–32 | 69 | 15 | 5 | 6–24 | |
RA ejection fraction (%)a | 66 | 50 | 9 | 32–68 | 69 | 56 | 9 | 38–74 | |
Simpson’s method; RA appendage excluded | Max. RA volume (ml)a | 66 | 89 | 22 | 46–132 | 69 | 77 | 16 | 45–108 |
Max. RA volume/BSA (ml/m2)a | 66 | 52 | 12 | 28–76 | 69 | 51 | 10 | 31–71 | |
Min. RA volume (ml)a | 66 | 46 | 16 | 14–79 | 69 | 35 | 9 | 17–53 | |
Min. RA volume/BSA (ml/m2)a | 66 | 27 | 9 | 9–45 | 69 | 23 | 6 | 12–35 | |
RA ejection fraction (%)a | 66 | 49 | 10 | 29–69 | 69 | 54 | 9 | 36–72 | |
Simpson’s method; RA appendage included | Max. RA volume (ml)b | 256 | 108 | 25 | 59–158 | 298 | 85 | 18 | 49–122 |
Max. RA volume/BSA (ml/m2)b | 256 | 56 | 12 | 32–79 | 298 | 50 | 10 | 31–69 | |
Min. RA volume (ml)c | 196 | 50 | 17 | 16–84 | 238 | 33 | 11 | 11–55 | |
Min. RA volume/BSA (ml/m2)c | 196 | 26 | 8 | 10–42 | 238 | 20 | 6 | 8–32 | |
RA stroke volume (ml)c | 196 | 58 | 16 | 26–90 | 238 | 47 | 12 | 23–71 | |
RA stroke volume/BSA (ml/m2)c | 196 | 30 | 8 | 14–46 | 238 | 28 | 7 | 14–42 | |
RA ejection fraction (%)c | 196 | 54 | 10 | 34–74 | 238 | 59 | 9 | 41–77 |
Parameter | Men | Women | ||||||
---|---|---|---|---|---|---|---|---|
n | Meanp | SDp | LL–ULd | n | Meanp | SDp | LL–ULd | |
Max. RA area 2Ch (cm2)a | 60 | 23 | 4 | 15–31 | 60 | 21 | 4 | 13–29 |
Max. RA area 2Ch/BSA (cm2/m2)a | 60 | 12 | 2 | 7–17 | 60 | 12 | 2 | 7–17 |
Max. RA area 4Ch (cm2)b | 324 | 21 | 4 | 13–30 | 284 | 19 | 3 | 12–26 |
Max. RA area 4Ch/BSA (cm2/m2)b | 324 | 11 | 2 | 7–15 | 284 | 12 | 2 | 8–15 |
Max. RA longitudinal diameter 2Ch (cm)c | 126 | 5.5 | 0.6 | 4.2–6.7 | 129 | 5.1 | 0.6 | 3.9–6.3 |
Max. RA longitudinal diameter 2Ch/BSA (cm/m2)c | 126 | 3.0 | 0.4 | 2.3–3.7 | 129 | 3.2 | 0.4 | 2.3–4.1 |
Max. RA transverse diameter 2Ch (cm)c | 126 | 4.2 | 0.9 | 2.4–6.0 | 129 | 4.1 | 0.9 | 2.4–5.9 |
Max. RA transverse diameter 2Ch/BSA (cm/m2)c | 126 | 2.3 | 0.5 | 1.3–3.3 | 129 | 2.6 | 0.6 | 1.5–3.7 |
Max. RA longitudinal diameter 4Ch (cm)c | 126 | 5.3 | 0.6 | 4.0–6.6 | 129 | 5.1 | 0.6 | 4.0–6.3 |
Max. RA longitudinal diameter 4Ch/BSA (cm/m2)c | 126 | 2.9 | 0.4 | 2.2–3.7 | 129 | 3.2 | 0.4 | 2.4–4.0 |
Max. RA transverse diameter 4Ch (cm)c | 126 | 4.8 | 0.6 | 3.7–5.9 | 129 | 4.3 | 0.6 | 3.2–5.4 |
Max. RA transverse diameter 4Ch/BSA (cm/m2)c | 126 | 2.6 | 0.3 | 2.1–3.2 | 129 | 2.7 | 0.3 | 2.0–3.4 |
Additional RA function parameters
Left and right ventricular dimensions and function in children
Demographic parameters
Studies included in this review
First author, year | CMR technique | n, male:female | Age range (years) |
---|---|---|---|
van der Ven, 2019 [45] | 1.5 T, short axis bSSFP; dimensions of LV and RV; papillary muscles included in LV mass; RV mass measured at end-systole, major trabeculae included in RV mass when connected to the ventricular wall, trabeculae not connected to the wall included in RV volume | 68:73 | < 1–18 |
Sarikouch, 2011 [47] | 1.5 T, axial bSSFP; pulmonary veins, superior and inferior vena cava and coronary sinus excluded, atrial appendages included from/in left and right atrial volume, respectively | 56:59 | 4–20 |
CMR analysis methods
Left and right atrial dimensions and function in children
CMR acquisition parameters
CMR analysis methods
Demographic parameters
Studies included in this review
Agea | Left atrium | Right atrium | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
LMS-parameters | Percentiles (ml/m2) | LMS-parameters | Percentiles (ml/m2) | |||||||||
L | M | S | P3 | P50 | P97 | L | M | S | P3 | P50 | P97 | |
6 | 1.378 | 36.715 | 0.263 | 14 | 37 | 55 | 1.806 | 33.342 | 0.191 | 20 | 39 | 68 |
7 | 1.378 | 38.610 | 0.246 | 17 | 39 | 56 | 1.806 | 48.385 | 0.203 | 22 | 43 | 71 |
8 | 1.378 | 40.291 | 0.229 | 20 | 40 | 57 | 1.806 | 51.247 | 0.205 | 24 | 47 | 73 |
9 | 1.378 | 41.762 | 0.212 | 22 | 42 | 58 | 1.806 | 51.742 | 0.205 | 26 | 49 | 74 |
10 | 1.378 | 43.375 | 0.197 | 25 | 43 | 59 | 1.806 | 52.579 | 0.204 | 28 | 52 | 75 |
11 | 1.378 | 45.120 | 0.183 | 27 | 45 | 61 | 1.806 | 54.891 | 0.200 | 30 | 54 | 76 |
12 | 1.378 | 46.671 | 0.171 | 29 | 47 | 62 | 1.806 | 56.348 | 0.197 | 32 | 57 | 77 |
13 | 1.378 | 47.784 | 0.161 | 31 | 48 | 62 | 1.806 | 57.830 | 0.193 | 33 | 59 | 78 |
14 | 1.378 | 48.331 | 0.152 | 33 | 48 | 62 | 1.806 | 59.473 | 0.188 | 34 | 61 | 79 |
15 | 1.378 | 48.581 | 0.142 | 34 | 49 | 62 | 1.806 | 61.042 | 0.181 | 35 | 63 | 80 |
16 | 1.378 | 49.112 | 0.131 | 36 | 49 | 61 | 1.806 | 63.114 | 0.171 | 37 | 65 | 81 |
17 | 1.378 | 50.353 | 0.120 | 38 | 50 | 62 | 1.806 | 64.322 | 0.161 | 38 | 67 | 82 |
18 | 1.378 | 52.583 | 0.111 | 40 | 53 | 64 | 1.806 | 66.227 | 0.145 | 40 | 69 | 84 |
19 | 1.378 | 55.860 | 0.103 | 44 | 56 | 67 | 1.806 | 72.157 | 0.110 | 43 | 71 | 85 |
20 | 1.378 | 59.928 | 0.097 | 48 | 60 | 71 | 1.806 | 77.498 | 0.064 | 45 | 72 | 86 |
Agea | Left atrium | Right atrium | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
LMS-parameters | Percentiles (ml/m2) | LMS-parameters | Percentiles (ml/m2) | |||||||||
L | M | S | P3 | P50 | P97 | L | M | S | P3 | P50 | P97 | |
4 | − 1.100 | 37.566 | 0.248 | 22 | 34 | 44 | 0.889 | 47.196 | 0.328 | 18 | 47 | 79 |
5 | − 0.956 | 38.333 | 0.242 | 23 | 36 | 46 | 0.774 | 47.386 | 0.318 | 20 | 47 | 80 |
6 | − 0.717 | 39.568 | 0.234 | 25 | 39 | 50 | 0.587 | 47.733 | 0.302 | 23 | 48 | 80 |
7 | − 0.478 | 40.739 | 0.225 | 26 | 41 | 53 | 0.421 | 48.181 | 0.284 | 25 | 48 | 80 |
8 | − 0.239 | 41.934 | 0.217 | 28 | 43 | 55 | 0.266 | 48.837 | 0.265 | 28 | 49 | 80 |
9 | 0.000 | 43.072 | 0.208 | 28 | 44 | 56 | 0.106 | 49.868 | 0.244 | 30 | 50 | 80 |
10 | 0.239 | 43.953 | 0.199 | 28 | 44 | 56 | -0.033 | 51.098 | 0.221 | 33 | 51 | 80 |
11 | 0.478 | 44.548 | 0.191 | 29 | 44 | 57 | -0.071 | 52.283 | 0.197 | 35 | 52 | 78 |
12 | 0.717 | 45.080 | 0.182 | 29 | 45 | 58 | 0.029 | 53.388 | 0.175 | 38 | 53 | 76 |
13 | 0.956 | 45.636 | 0.173 | 30 | 45 | 59 | 0.262 | 54.329 | 0.157 | 39 | 54 | 73 |
14 | 1.195 | 46.118 | 0.165 | 30 | 46 | 60 | 0.595 | 55.205 | 0.147 | 40 | 55 | 72 |
15 | 1.434 | 46.070 | 0.156 | 30 | 47 | 60 | 0.991 | 55.815 | 0.145 | 40 | 56 | 72 |
16 | 1.673 | 45.343 | 0.148 | 30 | 46 | 59 | 1.419 | 56.153 | 0.148 | 38 | 56 | 72 |
17 | 1.912 | 44.258 | 0.139 | 29 | 44 | 57 | 1.852 | 56.470 | 0.155 | 36 | 56 | 72 |
18 | 2.151 | 43.116 | 0.130 | 28 | 42 | 55 | 2.276 | 57.000 | 0.164 | 31 | 57 | 73 |
Cardiac chamber size in the athlete
CMR analysis methods
Demographic parameters
Studies included in this review
First author, year | CMR technique | n, gender, sports intensity | Age range (years) |
---|---|---|---|
Prakken, 2010 [50] | 1.5 T, short axis bSSFP, papillary muscles included in LV volume | 83, male, regular athletes (9–18 h/week) | 18–39 |
46, male, elite athletes (> 18 h/week) | 18–39 | ||
60, female, regular athletes (9–18 h/week) | 18–39 | ||
33, female, elite athletes (> 18 h/week) | 18–39 | ||
56, male, non-athletes | 18–39 | ||
58, female, non-athletes | 18–39 |
Parameter | Non-athletes [mean ± SD (LL–UL)c] | Regular athletesa [mean ± SD (LL–UL)c] | Elite athletesb [mean ± SD (LL–UL)c] | |||
---|---|---|---|---|---|---|
Men (n = 56) | Women (n = 58) | Men (n = 83) | Women (n = 60) | Men (n = 46) | Women (n = 33) | |
LVEDV (ml) | 201 ± 33 (135–267) | 156 ± 22 (112–200) | 250 ± 32 (186–314) | 194 ± 27 (140–248) | 261 ± 39 (183–339) | 199 ± 31 (137–261) |
LVEDV/BSA (ml/m2) | 101 ± 15 (71–131) | 90 ± 11 (68–112) | 123 ± 13 (97–149) | 107 ± 14 (79–135) | 129 ± 17 (95–163) | 107 ± 14 (79–135) |
LVESV (ml) | 87 ± 19 (49–125) | 65 ± 13 (39–91) | 108 ± 20 (68–148) | 86 ± 15 (56–116) | 117 ± 24 (69–165) | 85 ± 20 (45–125) |
LVESV/BSA (ml/m2) | 43 ± 10 (23–63) | 37 ± 7 (23–51) | 53 ± 9 (35–71) | 48 ± 8 (32–64) | 58 ± 11 (36–80) | 46 ± 11 (24–68) |
LVM (g) | 95 ± 20 (55–135) | 60 ± 11 (38–82) | 125 ± 22 (81–169) | 84 ± 17 (50–118) | 139 ± 28 (83–195) | 92 ± 15 (62–122) |
LVM/BSA (g/m2) | 48 ± 9 (30–66) | 34 ± 6 (22–46) | 62 ± 11 (40–84) | 46 ± 9 (28–64) | 69 ± 13 (43–95) | 50 ± 8 (34–66) |
LVEF (%) | 57 ± 6 (45–69) | 58 ± 5 (48–68) | 57 ± 5 (47–67) | 55 ± 4 (47–63) | 55 ± 5 (45–65) | 58 ± 7 (44–72) |
max. IVS (mm) | 10 ± 1 (8–12) | 5 ± 1 (3–7) | 11 ± 1 (9–13) | 9 ± 1 (7–11) | 11 ± 1 (9–13) | 9 ± 1 (7–11) |
Parameter | Non-athletes [mean ± SD (LL–UL)c] | Regular athletesa [mean ± SD (LL–UL)c] | Elite athletesb [mean ± SD (LL–UL)c] | |||
---|---|---|---|---|---|---|
Men (n = 56) | Women (n = 58) | Men (n = 83) | Women (n = 60) | Men (n = 46) | Women (n = 33) | |
RVEDV (ml) | 223 ± 40 (143–303) | 166 ± 23 (120–212) | 277 ± 36 (205–349) | 209 ± 29 (151–267) | 291 ± 48 (195–387) | 219 ± 35 (149–289) |
RVEDV/BSA (ml/m2) | 111 ± 18 (75–147) | 96 ± 12 (72–120) | 136 ± 16 (104–168) | 115 ± 15 (85–145) | 144 ± 20 (104–184) | 118 ± 17 (84–152) |
RVESV (ml) | 108 ± 24 (60–156) | 75 ± 13 (49–101) | 135 ± 25 (85–185) | 102 ± 17 (68–136) | 148 ± 30 (88–208) | 103 ± 24 (55–151) |
RVESV/BSA (ml/m2) | 54 ± 12 (30–78) | 43 ± 7 (29–57) | 66 ± 12 (42–90) | 57 ± 9 (39–75) | 73 ± 13 (47–99) | 56 ± 13 (30–82) |
RVM (g) | 23 ± 5 (13–33) | 18 ± 4 (10–26) | 29 ± 6 (17–41) | 23 ± 4 (15–31) | 30 ± 6 (18–42) | 25 ± 5 (15–35) |
RVM/BSA (g/m2) | 12 ± 2 (8–16) | 10 ± 2 (6–14) | 14 ± 3 (8–20) | 13 ± 2 (9–17) | 15 ± 2 (11–19) | 14 ± 3 (8–20) |
RVEF (%) | 52 ± 5 (42–62) | 55 ± 5 (45–65) | 51 ± 4 (43–59) | 51 ± 4 (43–59) | 50 ± 4 (42–58) | 53 ± 7 (39–67) |
First author, year | CMR technique | n, male:female | Age range (years) |
---|---|---|---|
Dawson, 2011 [56] | 1.5 T, short axis bSSFP, 16 segments (apex excluded) | 60:60 | 20–80 |
Kawel, 2012 [55] | 1.5 T, short (16 segments, apex excluded) and long axis (12 segments) bSSFP | 131:169 | 54–91 |
Le Ven, 2015 [14] | 1.5 T, short axis bSSFP; 16 segments (apex excluded) | 196:238 | 18–36 |
Yeon, 2015 [25] | 1.5 T, short axis bSSFP; 2 segments (basal inferolateral and anteroseptal) | 340:512 | (men: 61 ± 8; women: 62 ± 9)a |
Aquaro, 2017 [18] | 1.5 T, short axis bSSFP; 2 segments (basal anterior septum, basal inferolateral wall) | 173:135 | 15–80 |
Normal thickness of the compact left ventricular myocardium in adults
CMR acquisition parameters
CMR analysis methods
Demographic parameters
Studies included in this review
Level | Segment | Men | Women | ||||||
---|---|---|---|---|---|---|---|---|---|
n | Meanp | SDp | LL–ULc | n | Meanp | SDp | LL–ULc | ||
Basal | 1a | 387 | 7.8 | 1.3 | 5–10 | 467 | 6.4 | 1.1 | 4–9 |
2b | 900 | 9.0 | 1.4 | 6–12 | 1114 | 7.6 | 1.2 | 5–10 | |
3a | 387 | 8.8 | 1.2 | 6–11 | 467 | 7.3 | 1.0 | 5–9 | |
4a | 387 | 7.9 | 1.2 | 6–10 | 467 | 6.4 | 1.0 | 4–8 | |
5b | 900 | 7.7 | 1.2 | 5–10 | 1114 | 6.3 | 1.1 | 4–9 | |
6a | 387 | 7.5 | 1.2 | 5–10 | 467 | 6.1 | 1.0 | 4–8 | |
Mid-cavity | 7a | 387 | 6.7 | 1.2 | 4–9 | 467 | 5.6 | 1.0 | 4–8 |
8a | 387 | 7.4 | 1.3 | 5–10 | 467 | 6.1 | 1.0 | 4–8 | |
9a | 387 | 7.9 | 1.2 | 6–10 | 467 | 6.6 | 1.0 | 5–9 | |
10a | 387 | 7.0 | 1.2 | 5–9 | 467 | 5.8 | 1.0 | 4–8 | |
11a | 387 | 6.5 | 1.4 | 4–9 | 467 | 5.3 | 1.0 | 3–7 | |
12a | 387 | 6.6 | 1.2 | 4–9 | 467 | 5.5 | 1.1 | 4–8 | |
Apical | 13a | 387 | 6.5 | 1.2 | 4–9 | 467 | 5.9 | 1.3 | 3–9 |
14a | 387 | 6.8 | 1.3 | 4–9 | 467 | 5.8 | 1.1 | 4–8 | |
15a | 387 | 6.1 | 1.1 | 4–8 | 467 | 5.2 | 1.0 | 3–7 | |
16a | 387 | 6.2 | 1.1 | 4–8 | 467 | 5.6 | 1.0 | 4–8 |
Level | Region | Men (n = 131) | Women (n = 169) | ||||
---|---|---|---|---|---|---|---|
Mean | SD | LL–ULa | Mean | SD | LL–ULa | ||
Basal | Anterior | 8.2 | 1.3 | 6–11 | 7 | 1.1 | 5–9 |
Inferior | 8.2 | 1.3 | 6–10 | 6.7 | 1.1 | 5–9 | |
Septal | 9.1 | 1.3 | 7–12 | 7.3 | 1.1 | 5–10 | |
Lateral | 7.6 | 1.3 | 5–10 | 6 | 1.1 | 4–8 | |
Mean | 8.3 | 1.0 | 6–10 | 6.8 | 0.9 | 5–9 | |
Mid-cavity | Anterior | 6 | 1.3 | 3–9 | 4.9 | 1.1 | 3–7 |
Inferior | 7.7 | 1.3 | 5–10 | 6.5 | 1.1 | 4–9 | |
Septal | 8.3 | 1.3 | 6–11 | 6.8 | 1.1 | 5–9 | |
Lateral | 6.6 | 1.3 | 4–9 | 5.3 | 1.1 | 3–8 | |
Mean | 7.2 | 1.0 | 5–9 | 6 | 1 | 4–8 | |
Apical | Anterior | 5.1 | 1.3 | 3–8 | 4.2 | 1.1 | 2–6 |
Inferior | 5.8 | 1.3 | 3–8 | 5 | 1.1 | 3–7 | |
Septal | 5.8 | 1.3 | 3–8 | 5 | 1.1 | 3–7 | |
Lateral | 5.5 | 1.3 | 3–8 | 4.6 | 1.1 | 2–7 | |
Mean | 5.6 | 1.0 | 4–8 | 4.7 | 0.9 | 3–7 |
Normal values of left ventricular trabeculation
CMR acquisition parameters
First author, year | CMR technique | n, male:female | Age range (years) |
---|---|---|---|
Trabeculation thickness (thickness of the trabeculated [non-compacted] LV myocardium) | |||
Dawson, 2011 [56] | 1.5 T, short axis bSSFP, maximal thickness per segment at diastole and systole | 60:60 | 20–80 |
NC/C thickness ratio (thickness of trabeculated [non-compacted] LV myocardium/ thickness of compact LV myocardium) | |||
Dawson, 2011 [56] | 1.5 T, short axis bSSFP, NC/C thickness ratio per segment measured manually at the “peak of the most prominent trabeculae in each segment” at diastole and systole | 60:60 | 20–80 |
Kawel, 2012 [61] | 1.5 T, long axis bSSFP at diastole, maximal NC/C thickness ratio of 12 segments | 192:175 | 54–91 |
Captur, 2013 [59] | 1.5 T, long axis bSSFP at diastole, maximal NC/C thickness ratio of 16 segments | 40 (total)* | 18–85 |
Tizón-Marcos, 2014 [65] | 1.5 T, long- and short axis bSSFP, mean NC/C thickness ratio per segment measured semi-automatically by the centerline method (average of 20–30 chords/segment) at diastole and systole | 45:55 | 18–35 |
Amzulescu, 2015 [58] | 1.5 T and 3 T, long axis bSSFP at diastole, maximal NC/C thickness ratio of 16 segments | 22:26 | (60 ± 10)** |
André, 2015 [64] | 1.5T, long axis bSSFP at diastole,
maximal NC/C thickness ratio of
16 segments | 58:59 | 20– > 50 |
Trabeculation mass (mass of the trabeculated [non-compacted] LV myocardium) | |||
Bentatou, 2018 [12] | 1.5 T, short axis bSSFP at diastole, papillary muscles and blood between trabeculae excluded | 70:70 | 20–69 |
Trabeculation volume (volume of the trabeculated [non-compacted] LV myocardium) | |||
André, 2015 [64] | 1.5 T, short axis bSSFP, blood between trabeculae included, papillary muscles excluded | 58:59 | 20– > 50 |
NC/C mass ratio (mass of trabeculated [non-compacted] LV myocardium/ mass of compact LV myocardium) | |||
Amzulescu, 2015 [58] | 1.5 T and 3 T, short axis bSSFP at diastole, mass of trabeculated myocardium includes trabeculae and blood between trabeculae, papillary muscles excluded from trabeculated and compact mass | 22:26 | (60 ± 10)b |
Bentatou, 2018 [12] | 1.5 T, short axis bSSFP at diastole, blood between trabeculae excluded from mass of trabeculated myocardium, papillary muscles included in mass of compact myocardium | 70:70 | 20–69 |
NC/TM (mass of trabeculated [non-compacted] LV myocardium/ total LV myocardial mass [trabeculated + compact LV myocardial mass]) | |||
Captur, 2013 [59] | 1.5 T, short axis bSSFP at diastole, mass of trabeculated myocardium includes trabeculae and blood between trabeculae, papillary muscles included in mass of compact myocardium | 40 (total)a | 18–85 |
Fractal dimension (fractal complexity of LV trabeculated [non-compacted] myocardium) | |||
Captur, 2013 [59] | 1.5 T, short axis bSSFP at diastole, papillary muscles included in the endocardial complexity | 51:54 (75 white, 30 black) | 18–85 |
Captur 2015 [62] | 1.5 T, short axis bSSFP at diastole, papillary muscles included in the endocardial complexity | 279:325 | 46–91 |
Cai, 2017 [66] | 3 T, short axis bSSFP at diastole, papillary muscles included in the endocardial complexity | 91:89 | 20–69 |
CMR analysis methods
Level | Segment | Mean (median) | SD (IQR) |
---|---|---|---|
Basal | 1 | 3.0 | 0, 4.6 |
2 | 0 | ||
3 | 0 | ||
4 | 0 | ||
5 | 0 | 0, 3.9 | |
6 | 0 | 0, 4.1 | |
Mid-cavity | 7 | 5.6 | 2.8 |
8 | 0 | ||
9 | 0 | ||
10 | 0 | 0, 2.1 | |
11 | 4.2 | 2.5 | |
12 | 4.4 | 2.7 | |
Apical | 13 | 5.6 | 2.7 |
14 | 0 | ||
15 | 0 | 0, 4.5 | |
16 | 7.1 | 2.4 |
Parameter | Technique | Men | Women | ||||
---|---|---|---|---|---|---|---|
n | Mean | SD | n | Mean | SD | ||
Trabeculation mass (mass of the trabeculated [non-compacted] LV myocardium) per BSA (g/m2) from ref [12] | Papillary muscles and blood between trabeculae excluded | 70 | 5.4 | 2.3 | 70 | 4.0 | 2.3 |
Trabeculation volume (volume of the trabeculated [non-compacted] LV myocardium) per BSA (ml/m2) from ref [64] | Blood between trabeculae included, papillary muscles excluded | 58 | 43.1 | 8.7 | 59 | 36.1 | 5.2 |
Parameter | Ethnicity | n | Mean | SD |
---|---|---|---|---|
Global FD from ref [59] | Black | 30 | 1.246 | 0.005 |
Maximal apical FDa from ref [59] | Black | 30 | 1.235 | 0.03 |
Global FD from ref [59] | White | 75 | 1.228 | 0.002 |
Maximal apical FDa from ref [59] | White | 75 | 1.253 | 0.025 |
Global FD from ref [66] | Singaporean Chinese | 180 | 1.205 | 0.031 |
Maximal apical FDb from ref [66] | Singaporean Chinese | 180 | 0.278 | 0.045 |
Parameter | BMI ≥ 30 kg/m2 (mean ± SD) | BMI ≥ 25 to < 30 kg/m2 (mean ± SD) | BMI < 25 kg/m2 (mean ± SD) | ||||||
---|---|---|---|---|---|---|---|---|---|
All (n = 163) | Men (n = 71) | Women (n = 92) | All (n = 206) | Men (n = 108) | Women (n = 98) | All (n = 235) | Men (n = 100) | Women (n = 135) | |
Max. apical FDa | 1.203 ± 0.06 | 1.212 ± 0.07 | 1.196 ± 0.06 | 1.194 ± 0.06 | 1.197 ± 0.05 | 1.190 ± 0.07 | 1.169 ± 0.07 | 1.177 ± 0.06 | 1.162 ± 0.05 |
Demographic parameters
Studies included in this review
Cardiac valves and quantification of flow
CMR acquisition parameters
CMR analysis methods
Demographic parameters
Studies included in this review
Valve disease | Parameter | Stage | |
---|---|---|---|
Progressive | Severe | ||
Aortic stenosis | Maximum velocity (m/s) | Mild: 2.0–2.9 Moderate: 3.0–3.9 | Severe: ≥ 4 Very severe: ≥ 5 Low-flow/low-gradient: < 4 m/s (at rest) |
Orifice area (cm2) | ≤ 1.0 | ||
Orifice area /BSA (cm2/m2) | ≤ 0.6 | ||
Aortic regurgitation | Regurgitant volume (ml/beat) | Mild: < 30 Moderate: 30–59 | ≥ 60 |
Regurgitant fraction (%) | Mild: < 30 Moderate: 30–49 | ≥ 50 | |
Effective regurgitant orifice (cm2) | Mild: < 0.10 Moderate 0.10–0.29 | ≥ 0.30 | |
Mitral stenosis | Transmitral flow velocity (m/s) | Increased | |
Orifice area (cm2) | > 1.5 | Severe: ≤ 1.5 Very severe: ≤ 1.0 | |
Primary mitral regurgitation | Regurgitant volume (ml/beat) | < 60 | ≥ 60 |
Regurgitant fraction (%) | < 50 | ≥ 50 | |
Effective regurgitant orifice (cm2) | < 0.40 | ≥ 0.40 | |
Secondary mitral regurgitation | Regurgitant volume (ml/beat) | < 60 | ≥ 60 |
Regurgitant fraction (%) | < 50 | ≥ 50 | |
Effective regurgitant orifice (cm2) | < 0.40 | ≥ 0.40 | |
Pulmonic stenosis | Peak velocity (m/s) | > 4 | |
Tricuspid stenosis | Orifice area (cm2) | < 1.0 |
Parameter | Normal | Type 1 (Impaired relaxation) | Type 2 (Pseudonormal) | Type 3 (Restrictive, partially reversible) | Type 3 (Restrictive, fixed) |
---|---|---|---|---|---|
MDT (ms) | 150–220 | Increased | Normal | Decreased | Decreased |
E/A ratio | 1–2 | < 1 | 1–2 | > 2 | > 2 |
Parameter | 18–33 years | 34–60 years | > 60 years | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
n | Mean | SD | LL–ULa | n | Mean | SD | LL–ULa | n | Mean | SD | LL–ULa | |
Velocity (cm/s) | 64 | 66 | 15 | 36–96 | 116 | 51 | 13 | 25–77 | 67 | 35 | 12 | 11–59 |
Parameter | Men | Women | ||||||
---|---|---|---|---|---|---|---|---|
n | Mean | SD | LL–ULa | n | mean | SD | LL–ULa | |
Velocity (m/s) | 57 | 1.3 | 0.3 | 0.8–1.8 | 41 | 1.2 | 0.2 | 0.8–1.6 |
Normal aortic dimensions in the adult
CMR acquisition parameters
CMR analysis methods
Demographic parameters
Studies included in this review
First author, year | CMR technique | n, male:female | Age range (years) |
---|---|---|---|
Burman, 2008 [85] | 1.5 T, cine bSSFP, luminal diameter at systole and diastole, average of 3 cusp-commissure and 3 cusp-cusp diameters, respectively on cross-sectional images of the aortic sinus and diameter of the aortic sinus on the sagittal LVOT plane | 60:60 | 20–80 |
Davis, 2014 [86] | 1.5 T, cine bSSFP, maximal luminal diameter at diastole, diameters calculated based on measurements of the area at 3 levels (ascending aorta, proximal and distal descending aorta) of the aorta on cross-sectional images and diameters at 3 levels (annulus, sinus, sinotubular junction) of the aortic root measured on the sagittal LVOT plane | 208:239 | 19–70 |
Turkbey, 2014 [83] | 1.5 T, luminal diameter of the ascending aorta measured on the magnitude image of a phase contrast sequence | 770:842 | 45–84 |
Eikendal, 2016 [84] | 3 T, fat suppressed 3D-T1-black blood VISTA acquired sagittal of the descending aorta, luminal and total vessel diameter and area, calculated average diameter, luminal and total vessel area, vessel wall area and thickness of the proximal to distal descending aorta after manual tracing of the luminal and outer aortic wall on axial reformatted images | 59:65 | 25–35 |
Le, 2016 [11] | 3 T, cine bSSFP, luminal diameter of the aortic annulus, sinus and sinotubular junction at diastole measured on the sagittal LVOT plane | 91:89 | 20–69 |
Parameter | Men (n = 60) [mean ± SD (LL–UL) a] | Women (n = 60) [mean ± SD (LL–UL)a] | ||
---|---|---|---|---|
Systolic | Diastolic | Systolic | Diastolic | |
Aortic sinus diameter (cusp-commissure) (mm) | 34 ± 3 (27–40) | 32 ± 4 (25–39) | 30 ± 3 (25–35) | 28 ± 3 (23–34) |
Aortic sinus diameter (cusp-commissure)/BSA (mm/m2) | 17 ± 2 (14–20) | 16 ± 2 (13–20) | 18 ± 2 (14–21) | 17 ± 2 (13–20) |
Aortic sinus diameter (cusp-cusp) (mm) | 36 ± 4 (28–44) | 35 ± 4 (27–43) | 32 ± 3 (26–38) | 31 ± 3 (24–37) |
Aortic sinus diameter (cusp-cusp)/BSA (mm/m2) | 18 ± 2 (14–22) | 18 ± 2 (14–22) | 19 ± 2 (15–23) | 18 ± 2 (14–22) |
Aortic sinus area (cm2) | 9.2 ± 2.1 (5.0–13.4) | 8.4 ± 2.0 (4.4–12.4) | 7.1 ± 1.4 (4.3–9.9) | 6.5 ± 1.3 (3.9–9.1) |
Aortic sinus area/BSA (cm2/m2) | 4.6 ± 1.0 (2.6–6.6) | 4.2 ± 0.9 (2.4–6.0) | 4.2 ± 0.8 (2.6–5.8) | 3.8 ± 0.8 (2.2–5.4) |
Level | Men (n = 208) Mean ± SD (LL–UL)a | Women (n = 239) Mean ± SD (LL–UL)a |
---|---|---|
Ascending aorta diameter (mm) | 27 ± 4 (19–34) | 26 ± 4 (18–33) |
Proximal descending aorta diameter (mm) | 21 ± 3 (15–26) | 19 ± 2 (15–23) |
Distal descending aorta diameter (mm) | 18 ± 3 (13–23) | 16 ± 2 (12–20) |
Age (years) | Men (n = 770) Median (5th–95th percentile) | Women (n = 842) Median (5th–95th percentile) |
---|---|---|
Absolute values (mm) | ||
45–54 | 32 (27–37) | 29 (25–34) |
55–64 | 33 (28–41) | 30 (26–36) |
65–74 | 34 (29–41) | 31 (26–36) |
75–84 | 35 (29–41) | 31 (27–37) |
Values indexed to BSA (mm/m2) | ||
45–54 | 16 (13–20) | 17 (14–21) |
55–64 | 17 (14–21) | 18 (15–22) |
65–74 | 18 (14–22) | 18 (15–22) |
75–84 | 19 (15–23) | 20 (15–28) |
Parameter | Men (n = 59) Median (10th–90th percentile) | Women (n = 65) Median (10th–90th percentile) |
---|---|---|
Luminal diameter descending aorta (mm) | 19 (17–21) | 17 (16–19) |
Total diameter descending aorta (mm) | 22 (20–24) | 20 (19–22) |
Luminal area descending aorta (cm2) | 2.9 (2.2–3.5) | 2.3 (2.0–2.8) |
Total area descending aorta (cm2) | 3.9 (3.1–4.6) | 3.3 (2.8–3.9) |
Wall area descending aorta (cm2) | 1.0 (0.8–1.2) | 1.0 (0.8–1.1) |
Wall thickness descending aorta (mm) | 1.5 (1.4–1.8) | 1.5 (1.4–1.9) |
Parameter | Men | Women | ||||||
---|---|---|---|---|---|---|---|---|
n | Meanp | SDp | LL–ULe | n | Meanp | SDp | LL–ULe | |
Aortic annulus diameter (mm)a | 299 | 23 | 5 | 14–33 | 328 | 20 | 3 | 14–27 |
Aortic annulus diameter/BSA (mm/m2)b | 91 | 12 | 1 | 10–14 | 89 | 12 | 1 | 10–14 |
Aortic sinus diameter (mm)c | 359 | 32 | 6 | 19–45 | 388 | 28 | 5 | 17–38 |
Aortic sinus diameter/BSA (ml/m2)d | 151 | 17 | 2 | 13–21 | 149 | 17 | 2 | 13–21 |
Sinotubular junction diameter (mm)a | 299 | 25 | 6 | 12–38 | 328 | 21 | 5 | 12–31 |
Sinotubular junction diameter/BSA (mm/m2)b | 91 | 13 | 2 | 10–17 | 89 | 14 | 2 | 10–17 |
Normal aortic dimensions in children
CMR acquisition parameters
First author, year | CMR technique | n, male:female | Age range (years) |
---|---|---|---|
Kaiser, 2008 [91] | 1.5 T; contrast enhanced CMRA; shortest diameter measured on cross-sectional reformatted images at 9 locations | 30:23 | 2–20 |
Kutty, 2012 [93] | 1.5 T; magnitude image of a through-plane free-breathing phase contrast sequence; cross-sectional area calculated based on measurement of the maximal external aortic diameter perpendicular to the vessel and perpendicular to the maximal diameter in systole 1 to 2 cm distal to the sinotubular junction | 55:50 | 4–20 |
Voges, 2012 [92] | 3 T; cross sectional cine gradient echo images acquired at 4 positions perpendicular to the aortic axis, measurements obtained at maximal distension of the aorta | 30:41 | 2–28 |
CMR analysis methods
Demographic parameters
Studies included in this review
Agea | Ascending aorta | Aortic arch | Aortic isthmus | Descending aortab | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
L | M | S | L | M | S | L | M | S | L | M | S | |
< 1 | 0.3091 | 91.5360 | 0.1207 | 0.8668 | 80.1737 | 0.1898 | 0.1267 | 53.0050 | 0.1987 | 1.5823 | 44.6080 | 0.1100 |
1 | 0.3091 | 120.6960 | 0.1274 | 0.8668 | 101.7001 | 0.1897 | 0.1267 | 68.7198 | 0.1974 | 1.5823 | 57.0317 | 0.1115 |
2 | 0.3091 | 149.8560 | 0.1341 | 0.8668 | 123.2265 | 0.1895 | 0.1267 | 84.4347 | 0.1960 | 1.5823 | 69.4554 | 0.1129 |
3 | 0.3091 | 179.0160 | 0.1408 | 0.8668 | 144.7529 | 0.1894 | 0.1267 | 100.1495 | 0.1946 | 1.5823 | 81.8791 | 0.1143 |
4 | 0.3091 | 208.1812 | 0.1475 | 0.8668 | 166.2791 | 0.1893 | 0.1267 | 115.8653 | 0.1932 | 1.5823 | 94.3035 | 0.1158 |
5 | 0.3091 | 238.3791 | 0.1542 | 0.8668 | 187.7555 | 0.1891 | 0.1267 | 131.7743 | 0.1918 | 1.5823 | 106.8833 | 0.1172 |
6 | 0.3091 | 272.8715 | 0.1604 | 0.8668 | 208.8732 | 0.1890 | 0.1267 | 148.2790 | 0.1904 | 1.5823 | 119.9057 | 0.1186 |
7 | 0.3091 | 311.2493 | 0.1660 | 0.8668 | 229.2411 | 0.1888 | 0.1267 | 164.9648 | 0.1891 | 1.5823 | 133.0488 | 0.1201 |
8 | 0.3091 | 346.8686 | 0.1707 | 0.8668 | 248.8676 | 0.1887 | 0.1267 | 180.7624 | 0.1877 | 1.5823 | 145.5984 | 0.1215 |
9 | 0.3091 | 380.0230 | 0.1748 | 0.8668 | 268.0557 | 0.1886 | 0.1267 | 195.7825 | 0.1863 | 1.5823 | 157.5124 | 0.1229 |
10 | 0.3091 | 413.8181 | 0.1782 | 0.8668 | 287.2956 | 0.1884 | 0.1267 | 210.6578 | 0.1849 | 1.5823 | 169.3366 | 0.1244 |
11 | 0.3091 | 446.7220 | 0.1812 | 0.8668 | 306.7317 | 0.1883 | 0.1267 | 225.5414 | 0.1835 | 1.5823 | 181.3951 | 0.1258 |
12 | 0.3091 | 476.5703 | 0.1841 | 0.8668 | 326.2205 | 0.1881 | 0.1267 | 240.3324 | 0.1822 | 1.5823 | 193.8192 | 0.1272 |
13 | 0.3091 | 501.7973 | 0.1870 | 0.8668 | 345.4511 | 0.1880 | 0.1267 | 254.6975 | 0.1808 | 1.5823 | 206.4812 | 0.1287 |
14 | 0.3091 | 524.0769 | 0.1902 | 0.8668 | 364.2701 | 0.1879 | 0.1267 | 268.8289 | 0.1794 | 1.5823 | 219.2939 | 0.1301 |
15 | 0.3091 | 546.3695 | 0.1937 | 0.8668 | 382.7610 | 0.1877 | 0.1267 | 282.9653 | 0.1780 | 1.5823 | 232.0152 | 0.1316 |
16 | 0.3091 | 569.8955 | 0.1972 | 0.8668 | 400.9805 | 0.1876 | 0.1267 | 296.9424 | 0.1766 | 1.5823 | 244.3629 | 0.1330 |
17 | 0.3091 | 594.7536 | 0.2003 | 0.8668 | 418.9724 | 0.1875 | 0.1267 | 310.5833 | 0.1752 | 1.5823 | 256.2294 | 0.1344 |
18 | 0.3091 | 620.9611 | 0.2025 | 0.8668 | 436.7805 | 0.1873 | 0.1267 | 323.7094 | 0.1739 | 1.5823 | 267.5155 | 0.1359 |
19 | 0.3091 | 647.1204 | 0.2034 | 0.8668 | 454.4484 | 0.1872 | 0.1267 | 336.0814 | 0.1725 | 1.5823 | 278.0681 | 0.1373 |
20 | 0.3091 | 670.2706 | 0.2030 | 0.8668 | 472.0177 | 0.1871 | 0.1267 | 347.4348 | 0.1711 | 1.5823 | 287.6962 | 0.1387 |
21 | 0.3091 | 690.0681 | 0.2014 | 0.8668 | 489.5219 | 0.1869 | 0.1267 | 357.7775 | 0.1697 | 1.5823 | 296.3958 | 0.1402 |
22 | 0.3091 | 706.8583 | 0.1990 | 0.8668 | 506.9924 | 0.1868 | 0.1267 | 367.1860 | 0.1683 | 1.5823 | 304.2102 | 0.1416 |
23 | 0.3091 | 720.9831 | 0.1960 | 0.8668 | 524.4603 | 0.1866 | 0.1267 | 375.7366 | 0.1670 | 1.5823 | 311.1823 | 0.1430 |
24 | 0.3091 | 732.2902 | 0.1926 | 0.8668 | 541.9124 | 0.1865 | 0.1267 | 383.4824 | 0.1656 | 1.5823 | 317.3075 | 0.1445 |
25 | 0.3091 | 740.4053 | 0.1889 | 0.8668 | 559.3076 | 0.1864 | 0.1267 | 390.6086 | 0.1642 | 1.5823 | 322.5658 | 0.1459 |
26 | 0.3091 | 747.1815 | 0.1849 | 0.8668 | 576.7470 | 0.1862 | 0.1267 | 397.7409 | 0.1628 | 1.5823 | 327.1568 | 0.1473 |
27 | 0.3091 | 754.8518 | 0.1805 | 0.8668 | 594.3196 | 0.1861 | 0.1267 | 405.3735 | 0.1614 | 1.5823 | 331.4000 | 0.1488 |
28 | 0.3091 | 763.4054 | 0.1758 | 0.8668 | 611.9863 | 0.1860 | 0.1267 | 413.3799 | 0.1601 | 1.5823 | 335.4719 | 0.1502 |
29 | 0.3091 | 772.1960 | 0.1711 | 0.8668 | 629.6783 | 0.1858 | 0.1267 | 421.4867 | 0.1587 | 1.5823 | 339.4979 | 0.1516 |
30 | 0.3091 | 780.9891 | 0.1663 | 0.8668 | 647.3706 | 0.1857 | 0.1267 | 429.5945 | 0.1573 | 1.5823 | 343.5234 | 0.1531 |
Agea | Ascending aorta | Aortic arch | Aortic isthmus | Descending aortab | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
L | M | S | L | M | S | L | M | S | L | M | S | |
< 1 | − 0.7876 | 121.1903 | 0.2152 | 2.1750 | 73.6299 | 0.2114 | 0.1033 | 60.0696 | 0.1621 | 0.9371 | 41.0795 | 0.1398 |
1 | − 0.7876 | 145.9923 | 0.2140 | 2.1750 | 92.7307 | 0.2089 | 0.1033 | 72.6142 | 0.1617 | 0.9371 | 52.4930 | 0.1398 |
2 | − 0.7876 | 170.7944 | 0.2127 | 2.1750 | 111.8315 | 0.2064 | 0.1033 | 85.1587 | 0.1613 | 0.9371 | 63.9065 | 0.1398 |
3 | − 0.7876 | 195.5999 | 0.2114 | 2.1750 | 130.9296 | 0.2039 | 0.1033 | 97.7032 | 0.1609 | 0.9371 | 75.3185 | 0.1398 |
4 | − 0.7876 | 220.4539 | 0.2102 | 2.1750 | 149.9904 | 0.2013 | 0.1033 | 110.2465 | 0.1605 | 0.9371 | 86.7100 | 0.1398 |
5 | − 0.7876 | 245.4281 | 0.2089 | 2.1750 | 168.9588 | 0.1988 | 0.1033 | 122.7870 | 0.1601 | 0.9371 | 98.0510 | 0.1398 |
6 | − 0.7876 | 270.5738 | 0.2076 | 2.1750 | 187.8089 | 0.1963 | 0.1033 | 135.3263 | 0.1597 | 0.9371 | 109.3784 | 0.1398 |
7 | − 0.7876 | 295.9027 | 0.2064 | 2.1750 | 206.5696 | 0.1938 | 0.1033 | 147.8724 | 0.1593 | 0.9371 | 120.8531 | 0.1398 |
8 | − 0.7876 | 321.3290 | 0.2051 | 2.1750 | 225.2367 | 0.1913 | 0.1033 | 160.3915 | 0.1588 | 0.9371 | 132.5201 | 0.1398 |
9 | − 0.7876 | 346.5367 | 0.2038 | 2.1750 | 243.7024 | 0.1887 | 0.1033 | 172.7395 | 0.1584 | 0.9371 | 144.0843 | 0.1398 |
10 | − 0.7876 | 371.3379 | 0.2026 | 2.1750 | 261.8643 | 0.1862 | 0.1033 | 184.8049 | 0.1580 | 0.9371 | 155.3776 | 0.1398 |
11 | − 0.7876 | 395.6874 | 0.2013 | 2.1750 | 279.6207 | 0.1837 | 0.1033 | 196.5286 | 0.1576 | 0.9371 | 166.4608 | 0.1398 |
12 | − 0.7876 | 419.5583 | 0.2000 | 2.1750 | 296.8402 | 0.1812 | 0.1033 | 207.8452 | 0.1572 | 0.9371 | 177.3057 | 0.1398 |
13 | − 0.7876 | 442.8024 | 0.1988 | 2.1750 | 313.4236 | 0.1787 | 0.1033 | 218.7232 | 0.1568 | 0.9371 | 187.8984 | 0.1398 |
14 | − 0.7876 | 465.1326 | 0.1975 | 2.1750 | 329.2852 | 0.1761 | 0.1033 | 229.1136 | 0.1564 | 0.9371 | 198.1163 | 0.1398 |
15 | − 0.7876 | 486.2071 | 0.1962 | 2.1750 | 344.3674 | 0.1736 | 0.1033 | 238.9630 | 0.1560 | 0.9371 | 207.7776 | 0.1398 |
16 | − 0.7876 | 505.7398 | 0.1950 | 2.1750 | 358.6387 | 0.1711 | 0.1033 | 248.2461 | 0.1556 | 0.9371 | 216.7982 | 0.1398 |
17 | − 0.7876 | 523.5836 | 0.1937 | 2.1750 | 372.0983 | 0.1686 | 0.1033 | 256.9723 | 0.1552 | 0.9371 | 225.1710 | 0.1398 |
18 | − 0.7876 | 539.7165 | 0.1924 | 2.1750 | 384.7434 | 0.1661 | 0.1033 | 265.1479 | 0.1547 | 0.9371 | 232.7857 | 0.1398 |
19 | − 0.7876 | 554.1764 | 0.1912 | 2.1750 | 396.5833 | 0.1635 | 0.1033 | 272.7929 | 0.1543 | 0.9371 | 239.5830 | 0.1398 |
20 | − 0.7876 | 567.1207 | 0.1899 | 2.1750 | 407.6567 | 0.1610 | 0.1033 | 279.9469 | 0.1539 | 0.9371 | 245.6109 | 0.1398 |
21 | − 0.7876 | 578.7817 | 0.1886 | 2.1750 | 418.0442 | 0.1585 | 0.1033 | 286.6730 | 0.1535 | 0.9371 | 251.0496 | 0.1398 |
22 | − 0.7876 | 589.4770 | 0.1873 | 2.1750 | 427.8971 | 0.1560 | 0.1033 | 293.0630 | 0.1531 | 0.9371 | 256.1671 | 0.1398 |
23 | − 0.7876 | 599.5300 | 0.1861 | 2.1750 | 437.3887 | 0.1534 | 0.1033 | 299.2101 | 0.1527 | 0.9371 | 261.1406 | 0.1398 |
24 | − 0.7876 | 609.3164 | 0.1848 | 2.1750 | 446.7229 | 0.1509 | 0.1033 | 305.2232 | 0.1523 | 0.9371 | 266.1367 | 0.1398 |
25 | − 0.7876 | 619.1593 | 0.1835 | 2.1750 | 456.0570 | 0.1484 | 0.1033 | 311.2003 | 0.1518 | 0.9371 | 271.2515 | 0.1398 |
26 | − 0.7876 | 629.1747 | 0.1822 | 2.1750 | 465.4360 | 0.1459 | 0.1033 | 317.2057 | 0.1514 | 0.9371 | 276.5640 | 0.1398 |
27 | − 0.7876 | 639.3019 | 0.1810 | 2.1750 | 474.8382 | 0.1433 | 0.1033 | 323.2314 | 0.1510 | 0.9371 | 281.9813 | 0.1398 |
28 | − 0.7876 | 649.4860 | 0.1797 | 2.1750 | 484.2530 | 0.1408 | 0.1033 | 329.2650 | 0.1506 | 0.9371 | 287.4341 | 0.1398 |
29 | − 0.7876 | 659.6776 | 0.1784 | 2.1750 | 493.6694 | 0.1383 | 0.1033 | 335.2995 | 0.1502 | 0.9371 | 292.8916 | 0.1398 |
30 | − 0.7876 | 669.8691 | 0.1772 | 2.1750 | 503.0858 | 0.1358 | 0.1033 | 341.3341 | 0.1498 | 0.9371 | 298.3491 | 0.1398 |
Site | Predicted diameter (mm) | SD of residuals (mm) |
---|---|---|
Aortic sinus | 0.57 + 19.37*BSA0.5 | 2.38 |
Sinotubular junction | − 0.03 + 16.91*BSA0.5 | 1.92 |
Ascending aorta | − 1.33 + 18.6*BSA0.5 | 1.99 |
Proximal to the origin of the brachiocephalic artery | − 3.38 + 20.07*BSA0.5 | 1.69 |
First transverse segment | − 3.52 + 18.66*BSA0.5 | 1.63 |
Second transverse segment | − 2.63 + 16.5*BSA0.5 | 1.31 |
Isthmic región | − 3.37 + 16.52*BSA0.5 | 1.46 |
Descending aorta | − 1.12 + 14.42*BSA0.5 | 1.64 |
Thoracoabdominal aorta at the level of the diaphragm | 1.27 + 9.89*BSA0.5 | 1.34 |
Site | Predicted area (cm2) |
---|---|
Ascending aorta | − 0.0386 + 2.913*BSA |
Normal aortic distensibilityand pulse wave velocity (PWV) in adults
CMR acquisition parameters
CMR analysis methods
Demographic parameters
Studies included in this review
First author, year | CMR technique | n, male:female | Age range (years) |
---|---|---|---|
Kim, 2013 [98] | 1.5 T, phase contrast CMR to calculate PWV for 3 distances of the aorta; transit time calculated from the midpoint of the systolic up-slope on the flow versus time curve; cross sectional cine bSSFP at 4 levels of the aorta to calculate distensibility | 61:63 | 20–79 |
Eikendal, 2016 [84] | 3 T, phase contrast CMR to calculate PWV for 2 distances of the aorta, time delay calculated from velocity–time curves | 57:61 | 25–35 |
Level | Age (years) | Men (n = 61) Mean ± SD (10−3 mm/Hg) | Women (n = 63) Mean ± SD (10–3 mm/Hg) |
---|---|---|---|
Ascending aortaa | 20–29 | 5.6 ± 1.5 | 7.9 ± 3.4 |
30–39 | 3.6 ± 1.4 | 6.5 ± 3.0 | |
40–49 | 3.5 ± 1.5 | 5.3 ± 1.2 | |
50–59 | 3.2 ± 1.6 | 3.6 ± 1.1 | |
60–69 | 2.1 ± 1.3 | 2.7 ± 1.0 | |
Proximal descending aortaa | 20–29 | 4.2 ± 0.9 | 6.0 ± 1.4 |
30–39 | 3.8 ± 1.3 | 5.5 ± 1.9 | |
40–49 | 3.3 ± 0.6 | 4.2 ± 1.2 | |
50–59 | 2.9 ± 1.1 | 3.7 ± 1.3 | |
60–69 | 2.3 ± 0.9 | 3.1 ± 0.9 |
Age (years) | n | Median (5th–95th percentile) (m/s) |
---|---|---|
20–29 | 26 | 3.7 (3.4–4.0) |
30–39 | 28 | 3.8 (3.5–6.0) |
40–49 | 24 | 4.3 (3.7–5.0) |
50–59 | 25 | 5.6 (5.4–7.2) |
60–69 | 21 | 9.0 (7.4–12.4) |
Men (n = 57) Median (10th–90th percentile) (m/s) | Women (n = 61) Median (10th–90th percentile) (m/s) |
---|---|
4.6 (3.9–5.6) | 4.5 (3.6–6.0) |
Normal aortic distensibility and pulse wave velocity (PWV) in children
CMR acquisition parameters
CMR analysis methods
Demographic parameters
Studies included in this review
First author, year | CMR technique | n, male:female | Age range (years) |
---|---|---|---|
Voges, 2012 [92] | 3 T; cross sectional cine GRE at 4 levels of the thoracic aorta to calculate distensibility; phase contrast CMR to calculate PWV for the distance between the sinotubular junction and the proximal descending aorta, transit time calculated from the midpoint of the systolic up-slope on the flow versus time curve | 30:41 | 2–28 |
Age (years) | Male (n = 30) | Female (n = 41) | ||||
---|---|---|---|---|---|---|
L | M | S | L | M | S | |
< 1 | − 0.1879 | 12.3602 | 0.3680 | − 0.0721 | 12.7303 | 0.2388 |
1 | − 0.1879 | 11.9220 | 0.3680 | − 0.0721 | 12.5028 | 0.2396 |
2 | − 0.1879 | 11.4838 | 0.3680 | − 0.0721 | 12.2753 | 0.2403 |
3 | − 0.1879 | 11.0456 | 0.3680 | − 0.0721 | 12.0477 | 0.2411 |
4 | − 0.1879 | 10.6075 | 0.3680 | − 0.0721 | 11.8176 | 0.2419 |
5 | − 0.1879 | 10.1700 | 0.3680 | − 0.0721 | 11.5817 | 0.2427 |
6 | − 0.1879 | 9.7343 | 0.3680 | − 0.0721 | 11.3421 | 0.2435 |
7 | − 0.1879 | 9.2990 | 0.3680 | − 0.0721 | 11.1121 | 0.2443 |
8 | − 0.1879 | 8.8602 | 0.3680 | − 0.0721 | 10.9051 | 0.2451 |
9 | − 0.1879 | 8.4151 | 0.3680 | − 0.0721 | 10.7290 | 0.2459 |
10 | − 0.1879 | 7.9776 | 0.3680 | − 0.0721 | 10.5679 | 0.2467 |
11 | − 0.1879 | 7.5683 | 0.3680 | − 0.0721 | 10.3851 | 0.2474 |
12 | − 0.1879 | 7.2051 | 0.3680 | − 0.0721 | 10.1582 | 0.2482 |
13 | − 0.1879 | 6.9030 | 0.3680 | − 0.0721 | 9.8884 | 0.2490 |
14 | − 0.1879 | 6.6697 | 0.3680 | − 0.0721 | 9.5911 | 0.2498 |
15 | − 0.1879 | 6.5089 | 0.3680 | − 0.0721 | 9.2905 | 0.2506 |
16 | − 0.1879 | 6.4138 | 0.3680 | − 0.0721 | 9.0033 | 0.2514 |
17 | − 0.1879 | 6.3729 | 0.3680 | − 0.0721 | 8.7345 | 0.2522 |
18 | − 0.1879 | 6.3745 | 0.3680 | − 0.0721 | 8.4850 | 0.2529 |
19 | − 0.1879 | 6.4062 | 0.3680 | − 0.0721 | 8.2574 | 0.2537 |
20 | − 0.1879 | 6.4551 | 0.3680 | − 0.0721 | 8.0546 | 0.2545 |
21 | − 0.1879 | 6.5111 | 0.3680 | − 0.0721 | 7.8749 | 0.2553 |
22 | − 0.1879 | 6.5646 | 0.3680 | − 0.0721 | 7.7106 | 0.2561 |
23 | − 0.1879 | 6.6062 | 0.3680 | − 0.0721 | 7.5479 | 0.2569 |
24 | − 0.1879 | 6.6277 | 0.3680 | − 0.0721 | 7.3842 | 0.2577 |
25 | − 0.1879 | 6.6242 | 0.3680 | − 0.0721 | 7.2113 | 0.2584 |
26 | − 0.1879 | 6.5975 | 0.3680 | − 0.0721 | 7.0343 | 0.2592 |
27 | − 0.1879 | 6.5577 | 0.3680 | − 0.0721 | 6.8647 | 0.2600 |
28 | − 0.1879 | 6.5116 | 0.3680 | − 0.0721 | 6.6951 | 0.2608 |
29 | − 0.1879 | 6.4643 | 0.3680 | − 0.0721 | 6.5250 | 0.2616 |
30 | − 0.1879 | 6.4170 | 0.3680 | − 0.0721 | 6.3550 | 0.2624 |
Age (years) | Male (n = 30) | Female (n = 41) | ||||
---|---|---|---|---|---|---|
L | M | S | L | M | S | |
< 1 | 1.4844 | 3.4147 | 0.2122 | − 1.5196 | 2.7808 | 0.1468 |
1 | 1.4844 | 3.4367 | 0.2122 | − 1.5196 | 2.8144 | 0.1469 |
2 | 1.4844 | 3.4587 | 0.2122 | − 1.5196 | 2.8481 | 0.1469 |
3 | 1.4844 | 3.4808 | 0.2122 | − 1.5196 | 2.8817 | 0.1469 |
4 | 1.4844 | 3.5028 | 0.2122 | − 1.5196 | 2.9154 | 0.1470 |
5 | 1.4844 | 3.5248 | 0.2122 | − 1.5196 | 2.9490 | 0.1470 |
6 | 1.4844 | 3.5469 | 0.2122 | − 1.5196 | 2.9827 | 0.1470 |
7 | 1.4844 | 3.5689 | 0.2122 | − 1.5196 | 3.0163 | 0.1470 |
8 | 1.4844 | 3.5909 | 0.2122 | − 1.5196 | 3.0499 | 0.1471 |
9 | 1.4844 | 3.6129 | 0.2122 | − 1.5196 | 3.0836 | 0.1471 |
10 | 1.4844 | 3.6350 | 0.2122 | − 1.5196 | 3.1172 | 0.1471 |
11 | 1.4844 | 3.6570 | 0.2122 | − 1.5196 | 3.1509 | 0.1471 |
12 | 1.4844 | 3.6790 | 0.2122 | − 1.5196 | 3.1845 | 0.1472 |
13 | 1.4844 | 3.7011 | 0.2122 | − 1.5196 | 3.2182 | 0.1472 |
14 | 1.4844 | 3.7231 | 0.2122 | − 1.5196 | 3.2518 | 0.1472 |
15 | 1.4844 | 3.7451 | 0.2122 | − 1.5196 | 3.2855 | 0.1473 |
16 | 1.4844 | 3.7672 | 0.2122 | − 1.5196 | 3.3192 | 0.1473 |
17 | 1.4844 | 3.7892 | 0.2122 | − 1.5196 | 3.3528 | 0.1473 |
18 | 1.4844 | 3.8112 | 0.2122 | − 1.5196 | 3.3865 | 0.1473 |
19 | 1.4844 | 3.8333 | 0.2122 | − 1.5196 | 3.4201 | 0.1474 |
20 | 1.4844 | 3.8553 | 0.2122 | − 1.5196 | 3.4538 | 0.1474 |
21 | 1.4844 | 3.8773 | 0.2122 | − 1.5196 | 3.4875 | 0.1474 |
22 | 1.4844 | 3.8994 | 0.2122 | − 1.5196 | 3.5211 | 0.1475 |
23 | 1.4844 | 3.9214 | 0.2122 | − 1.5196 | 3.5548 | 0.1475 |
24 | 1.4844 | 3.9434 | 0.2122 | − 1.5196 | 3.5885 | 0.1475 |
25 | 1.4844 | 3.9655 | 0.2122 | − 1.5196 | 3.6221 | 0.1476 |
26 | 1.4844 | 3.9875 | 0.2122 | − 1.5196 | 3.6558 | 0.1476 |
27 | 1.4844 | 4.0096 | 0.2122 | − 1.5196 | 3.6895 | 0.1476 |
28 | 1.4844 | 4.0316 | 0.2122 | − 1.5196 | 3.7231 | 0.1476 |
29 | 1.4844 | 4.0536 | 0.2122 | − 1.5196 | 3.7568 | 0.1477 |
30 | 1.4844 | 4.0757 | 0.2122 | − 1.5196 | 3.7905 | 0.1477 |
Normal dimensions and distension of the pulmonary arteries in adults
CMR acquisition parameters
First author, year | CMR technique | n, male:female | Age range (years) |
---|---|---|---|
Burman, 2016 [99] | 1.5 T, cross sectional bSSFP, luminal area and mean diameters | 60:60 | 20–79 |
CMR analysis methods
Vessel | Parameter | Men (n = 60) | Women (n = 60) | ||||
---|---|---|---|---|---|---|---|
Mean | SD | LL–ULa | Mean | SD | LL–ULa | ||
MPA | Systolic diameter (mm) | 27.4 | 2.6 | 21–33 | 25.3 | 2.6 | 19–31 |
Diastolic diameter (mm) | 22.9 | 2.4 | 19–27 | 21.2 | 2.1 | 17–25 | |
Systolic area (cm2) | 5.9 | 1.1 | 3.7–8.1 | 5.0 | 1.0 | 3.0–7.0 | |
Diastolic area (cm2) | 4.2 | 0.8 | 2.6–5.8 | 3.6 | 0.7 | 2.2–5.0 | |
Distension (%) | 42.7 | 17.2 | 9–77 | 41.8 | 15.7 | 10–74 | |
RPA | Systolic diameter (mm) | 20.2 | 2.9 | 14–26 | 17.8 | 2.4 | 14–22 |
Diastolic diameter (mm) | 16.6 | 2.8 | 11–23 | 14.7 | 2.2 | 11–19 | |
Systolic area (cm2) | 3.3 | 1.0 | 1.3–5.3 | 2.6 | 0.7 | 1.2–4.0 | |
Diastolic area (cm2) | 2.2 | 0.8 | 0.6–3.8 | 1.8 | 0.6 | 0.6–3.0 | |
Distension (%) | 50.6 | 16.9 | 17–85 | 48.2 | 14.5 | 18–78 | |
LPA | Systolic diameter (mm) | 20.1 | 2.4 | 16–24 | 18.4 | 2.1 | 14–22 |
Diastolic diameter (mm) | 17.3 | 2.5 | 11–23 | 15.9 | 2.0 | 12–20 | |
Systolic area (cm2) | 3.3 | 0.8 | 1.7–4.9 | 2.8 | 0.6 | 1.6–4.0 | |
Diastolic area (cm2) | 2.4 | 0.7 | 1.0–3.8 | 2.1 | 0.5 | 1.1–3.1 | |
Distension (%) | 35.6 | 10.1 | 16–56 | 35.2 | 10.3 | 15–55 |
Demographic parameters
Studies included in this review
Normal dimensions of the pulmonary arteries in children
CMR acquisition parameters
CMR analysis methods
Demographic parameters
Studies included in this review
First author, year | CMR technique | n, male:female | Age range (years) |
---|---|---|---|
Knobel, 2011 [100] | 1.5 T, contrast enhanced CMRA, diameters measured on images perpendicular to the vessel | 41:28 | 2–20 |
Kutty, 2012 [93] | 1.5 T; magnitude image of a through-plane free-breathing phase contrast sequence; cross sectional area calculated based on measurements of the maximal external aortic diameter perpendicular to the vessel and perpendicular to the maximal diameter obtained midway between the level of the pulmonary valve and the bifurcation of the branch pulmonary arteries | 55:50 | 4–20 |
Site | Predicted diameter (mm) | SD of residuals (mm) |
---|---|---|
Main pulmonary artery (axial) | 4.85 + 13.43*BSA0.5 | 2.72 |
Main pulmonary artery (sagittal) | 1.04 + 17.07* BSA0.5 | 2.01 |
Proximal right pulmonary artery (axial) | 2.63 + 9.19* BSA0.5 | 1.65 |
Distal right pulmonary artery (axial) | 3.9 + 6.25* BSA0.5 | 1.49 |
Proximal right pulmonary artery (RAO) | − 0.69 + 14.3* BSA0.5 | 1.76 |
Distal right pulmonary artery (RAO) | − 1.08 + 14.62* BSA0.5 | 1.6 |
Proximal left pulmonary artery (axial) | 1.7 + 11.27* BSA0.5 | 1.37 |
Distal left pulmonary artery (axial) | − 0.1 + 11.89* BSA0.5 | 1.51 |
Proximal left pulmonary artery (LAO) | − 2.13 + 16.82* BSA0.5 | 1.88 |
Distal left pulmonary artery (LAO) | − 2.08 + 13.64* BSA0.5 | 1.5 |
Site | Predicted area (cm2) |
---|---|
Ascending aorta | − 0.2880 + 3.386*BSA |
Normal values of myocardial T1 relaxation time and the extracellular volume (ECV)
CMR acquisition parameters
Factors affecting T1 relaxation time and ECV
CMR analysis methods
Demographic parameters
Studies included in this review
First author, year | CMR technique | n, male:female | Age range or mean ± SD (years) |
---|---|---|---|
Fontana, 2012 [120] | 1.5 T, Siemens, ShMOLLI, ECV | 27:23 | 47 ± 17 |
Kellman, 2012 [121] | 1.5 T, Siemens, MOLLI, native T1 and ECV | 30:32 | 47 ± 17 |
Piechnik, 2013 [116] | 1.5 T, Siemens, ShMOLLI, native T1 | 169:173 | 11–69 |
Sado, 2013 [122] | 1.5 T, Siemens, ShMOLLI, native T1 | 30:37 | 24–88 |
Ferreira, 2014 [123] | 1.5 T, Siemens, ShMOLLI, native T1 | 37:13 | 41 ± 13 |
Fontana, 2014 [124] | 1.5 T, Siemens, ShMOLLI, native T1 | 17:35 | 46 ± 15 |
Liu, 2014 [125] | 3 T, Siemens, MOLLI, native T1 | 38:54 | 27–44 |
Puntmann, 2014 [126] | 3 T, Philips, MOLLI, native T1 | 47 (total) | –a |
Reiter, 2014 [118] | 1.5 T, Siemens, MOLLI, native T1 | 20:20 | 20–35 |
aus dem Siepen, 2015 [127] | 1.5 T, Philips, MOLLI, native T1 and ECV | 37:19 | 52 ± 9 |
Banypersad, 2015 [128] | 1.5 T, Siemens, ShMOLLI, native T1 and ECV | 25:29 | 46 ± 15 |
Edwards, 2015 [129] | 1.5 T, Siemens, MOLLI, native T1 and ECV | 24:19 | 57 ± 10 |
Fontana, 2015 [130] | 1.5 T, Siemens, ShMOLLI, native T1 and ECV | 21:26 | 24–69 |
Treibel, 2015 [131] | 1.5 T, Siemens, ShMOLLI, native T1 and ECV | 26:24 | 28–69 |
Goebel, 2015 [132] | 1.5 T, Siemens, MOLLI, native T1 | 31:23 | 18–63 |
Gormeli, 2016 [133] | 3 T, Siemens, MOLLI, native T1 | 26:15 | 24 ± 4 |
Hinojar, 2016 [134] | 3 T, Philips, MOLLI, native T1 | 9:37 | 42 ± 15 |
Ntusi, 2016 [135] | 1.5 T, Siemens, ShMOLLI, native T1 | 53:39 | 44 ± 10 |
Rauhalammi, 2016 [136] | 1.5 T and 3 T, Siemens, MOLLI, native T1 | 43: 41 | 45 ± 18 |
Costello, 2017 [137] | 3 T, Siemens, ShMOLLI, native T1 and ECV | 29:28 | 48 ± 15 |
Avitzur, 2018 [138] | 3 T, Siemens, ShMOLLI, native T1 | 83:57 | 54 ± 9 |
Doerner, 2018 [139] | 1.5 T, Philips, MOLLI, native T1 and ECV | 30:20 | 39 ± 17 |
Guo, 2018 [140] | 3 T, Philips, MOLLI, native T1 and ECV | 18:32 | 36 ± 16 |
Ridouani, 2018 [141] | 1.5 T, Siemens, MOLLI, native T1 | 20:20 | 40 ± 12 |
Rosmini, 2018 [142] | 1.5 T, Siemens, MOLLI and ShMOLLI, native T1 and ECV | 49:45 | 20–76 |
Shang, 2018 [143] | 3 T, Siemens, MOLLI, ECV | 45 (total) | –a |
Yang, 2018 [144] | 3 T, Siemens, MOLLI, native T1 and ECV | 18:26 | 33 ± 16 |
Granitz, 2019 [145] | 1.5 T and 3 T, Philips, MOLLI, native T1 | 26:32 | 42 ± 13 (male), 40 ± 14 (female) |
Imran, 2019 [146] | 1.5 T, Philips, MOLLI, native T1 | 26:25 | 46 ± 14 |
Lehmonen, 2019 [147] | 1.5 T, Siemens, ShMOLLI, native T1 | 46 (total) | 46 ± 9 |
Vijapurapu, 2019 [148] | 1.5 T, Siemens, ShMOLLI, native T1 | 40:37 | 49 ± 14 |
Wan, 2019 [149] | 3 T, Siemens, MOLLI, native T1 and ECV | 20:20 | 56 ± 9 |
Parameter | FS (T) | Vendor | Technique | n | Meanp | SDp | LL–ULm |
---|---|---|---|---|---|---|---|
Native T1 time (ms) | 1.5 | Siemens | MOLLI | 417a | 972 | 43 | 885–1059 |
1.5 | Siemens | ShMOLLI | 971b | 960 | 29 | 903–1017 | |
1.5 | Philips | MOLLI | 215c | 989 | 42 | 905–1073 | |
3 | Siemens | MOLLI | 301d | 1196 | 47 | 1103–1290 | |
3 | Siemens | ShMOLLI | 197e | 1130 | 55 | 1021–1240 | |
3 | Philips | MOLLI | 201f | 1097 | 66 | 964–1230 | |
ECV (%) | 1.5 | Siemens | MOLLI | 199 g | 26 | 3 | 20–32 |
1.5 | Siemens | ShMOLLI | 295 h | 27 | 3 | 21–33 | |
1.5 | Philips | MOLLI | 56i | 23 | 3 | 17–29 | |
3 | Siemens | MOLLI | 129j | 26 | 3 | 20–32 | |
3 | Siemens | ShMOLLI | 57 k | 25 | 2 | 20–29 | |
3 | Philips | MOLLI | 100 l | 26 | 5 | 16–36 |
Normal values of myocardial T2 relaxation times
CMR acquisition parameters
Factors affecting T2 relaxation time
CMR analysis methods
Demographic parameters
Studies included in this review
First author, year | FS (T) | Vendor | Technique | n, male:female | Age range or mean ± SD (years) | Mean | SD | LL–ULa |
---|---|---|---|---|---|---|---|---|
Wassmuth, 2013 [155] | 1.5 | Siemens | T2P bSSFP | 60:13 | 20–70 | 55 | 5 | 45–65 |
Wassmuth, 2013 [155] | 1.5 | Siemens | FLASH | 60:13 | 20–70 | 52 | 5 | 42–62 |
Hinojar, 2016 [134] | 3 | Philips | GSE | 9:37 | 42 ± 15 | 45 | 4 | 37–53 |
Ridouani, 2018 [141] | 1.5 | Siemens | T2P bSSFP | 20:20 | 40 ± 12 | 51 | 3 | 45–57 |
Granitz, 2019 [145] | 1.5 | Philips | GSE | 26:32 | 40 ± 14 (male), 42 ± 13 (female) | 56 | 3 | 50–62 |
Granitz, 2019 [145] | 3 | Philips | GSE | 26:32 | 40 ± 14 (male), 42 ± 13 (female) | 52 | 3 | 46–58 |
Normal values of myocardial T2* relaxation time
CMR acquisition parameters
CMR analysis methods
Demographic parameters
Studies included in this review
Regional measurements and cardiac strain
CMR acquisition parameters
CMR analysis methods
Demographic parameters
Studies included in this review
First author, year | CMR technique | n, male:female | Age range (years) |
---|---|---|---|
Neizel, 2009 [182] | 1.5 T, 3 short axis images, tagged CMR (SPAMM), tagged resolution 7 mm; HARP methodb | 40:35 | 22–69 |
Augustine, 2013 [177] | 1.5 T, short axis stack bSSFP, 2, 3, and 4 chamber bSSFP; feature tracking (TomTec softwarec) | 54:62 | (30 ± 8)a |
Venkatesh, 2015 [183] | 1.5 T, 3 short axis images, tagged CMR (SPAMM), tagged resolution 7 mm, HARP methodb | 46:83 | 45–84 |
Andre, 2015 [179] | 1.5 T, short axis stack, 2, 3, and 4 chamber bSSFP; feature tracking (TomTec softwarec) | 75:75 | 21–71 |
Cai, 2017 [66] | 3 T, short axis stack, 2, 3, and 4 chamber bSSFP; feature tracking (CVI42 softwared, 2D) | 91:89 | 20–69 |
Liu, 2018 [26] | 1.5 T, short axis stack bSSFP, 2, 3, and 4 chamber bSSFP; feature tracking (CVIR42 softwared, 3D) | 50:50 | 20–70 |
Peng, 2018 [176] | 1.5 T and 3 T, short axis stack, 2, 3, and 4 chamber bSSFP; feature tracking (QStrain softwaree) | 75:75 | 18–82 |
Parameter | n | Meanp | SDp | LL–ULa |
---|---|---|---|---|
Circumferential strain (%) | 204 | − 20.1 | 3.0 | − 26.0 to − 14.2 |
Parameter | Men | Women | ||||||
---|---|---|---|---|---|---|---|---|
n | Meanp | SDp | LL–ULa | n | Meanp | SDp | LL–ULa | |
Circumferential strain (%) | 295 | − 20.9 | 3.2 | − 27.2 to − 14.6 | 301 | − 22.7 | 3.3 | − 29.2 to − 16.2 |
Longitudinal strain (%) | 295 | − 19.4 | 3.3 | − 26.1 to − 12.7 | 301 | − 21.4 | 3.6 | − 28.7 to − 14.2 |
Parameter | n | Mean | SD | LL–ULa |
---|---|---|---|---|
Circumferential strain (%) | 100 | − 17.6 | 2.6 | − 22.8 to − 12.4 |
Longitudinal strain (%) | 100 | − 14.6 | 2.7 | − 20.0 to − 9.2 |
Myocardial perfusion
CMR acquisition parameters
CMR analysis methods
Demographic parameters
Studies included in this review
First author, year | CMR technique | n, male:female | Age mean ± SD (years) |
---|---|---|---|
Wang, 2006 [192] a | 1.5 T, T1weighted saturation recovery single-shot GRE, at rest and under adenosine stress | 49:50 | 59 ± 11 |
Madriago, 2015 [196] | 3 T, T1weighted saturation recovery single-shot GRE, at rest and under adenosine stress | 11:9 | 8 ± 5 |
Brown, 2018 [195] | 3 T, T1weighted saturation recovery single-shot GRE, at rest and under adenosine stress | 19:23 | 23 (22–29)b |
References | n | MBF at rest (ml/min/g) | MBF during Adenosine stress (ml/min/g) | Perfusion reservea |
---|---|---|---|---|
Mean ± SD (LL–UL)b | Mean ± SD (LL–UL)b | Mean ± SD (LL–UL)b | ||
Wang, 2006 [192] | 99 49 50 | All: 1.02 ± 0.24 (0.54–1.5) Men: 0.96 ± 0.23 (0.5–1.96) Women: 1.08 ± 0.23 (0.62–2.32) | All: 3.13 ± 0.80 (1.53–6.19) Men: 2.79 ± 0.72 (1.35–5.49) Women: 3.46 ± 0.73 (2.02–7.50) | All: 3.17 ± 0.87 (1.43–4.91) |
Madriago, 2015 [196] c | 20 | 0.94 ± 0.17 (0.6–1.28) | 2.34 ± 0.82 (0.7–3.98) | 2.63 ± 0.96 (0.71–4.55) |
Brown, 2018 [195] | 42 | 0.65 ± 0.13 (0.39–0.91) | 2.71 ± 0.61 (1.49–3.93) | 4.24 ± 0.69 (2.86–5.62) |
Artificial Intelligence (AI)-based segmentation methods for analysis of cine MRI
Data set | Conference/source | n | Segmented structure | Data description |
---|---|---|---|---|
MICCAI-2009 [213] | MICCAI 2009 | 45 | Left ventricle | Single center, single vendor 5 sub-groups: healthy, hypertrophy, heart failure with infarction and heart failure without infarction |
LVSC-2011 [214] | STACOM-2011 | 200 | Left ventricle | Multi center, multi-vendor Myocardial infarction |
RVSC-2012 [215] | MICCAI 2012 | 48 | Right ventricle | Single center Randomly selected clinical cases |
ACDC-2017 [198] | MICCAI 2017 | 150 | Left ventricle | Single center, 2 scanners, 1 vendor 5 sub-groups (Normal, post-myocardial infarction, dilated cardiomyopathy, hypertrophic cardiomyopathy, abnormal right ventricle) |
KAGGLE-2015 [216] | KAGGLE 2015s annual data science bow | 1100 | Left ventricle | Multi center, multi scanner Mix of patient and volunteer scans Only end-diastolic and end-systolic ground truth results provided. No gold standard segmentations available |
Multiple sources | Cardiac Atlas Project [217] | > 6500 | Left ventricle | Multi center, multi-vendor Asymptomatic subjects Data acquired with gradient echo cine acquisition Data hosted on: https://www.cardiacatlas.org/studies/mesa/ |
Studies included in this review
Author, year | Segmented structure | Data used for training/validation | Validation methods/remarks |
---|---|---|---|
Tran, 2017 [203] | LV + RV | LV: MICCAI-2009 (n = 45) RV: RVSC-2012 (n = 45) | Validation: auto vs manual Metrics: DICE, HD, ACD |
Bai, 2018 [2] | LV + RV Including LV, RV, LA, RA from long-axis cine | 4875 subjects UK Biobank cohort Multi-center, single vendor | Validation: auto vs manual Metrics: DICE, HD, APD LV: EDV, ESV, EF, SV, CO, LV mass RV: EDV, ESV, EF, CO |
Bernard, 2018 [198] | LV + RV | ACDC-2017 (n = 150) | Nine methods compared Validation: auto vs manual Metrics: DICE, HD, CLBR LV: EDV, ESV, EF, LV mass RV: EDV, ESV, EF |
Khened, 2018 [200] | LV + RV | KAGGLE-2015 (n = 1140) ACDC-2017 (n = 150) LVSC-2011 (n = 200) | Validation: auto vs manual Metrics: DICE, CLBR Patient diagnosis |
Tan, 2018 [201] | LV | LVSC-2011 (n = 200) KAGGLE-2015 (n = 1140) | Validation: auto vs manual Metrics: DICE, JI, HD EDV, ESV |
Tao, 2018 [3] | LV | Training: 400 subjects Testing: 150 subjects Multi-center, multi-vendor Multiple patient categories: MI (n = 322), DCM (n = 168), HCM (n = 23), DCM (n = 23), PH (n = 10) other (n = 27), normal (n = 23) | Validation: auto vs manual Metrics: DICE EDV, ESV, EF, LV mass |
Vigneault, 2018 [204] | LV + RV from multiple views | 53 subjects HCM (n = 42), healthy (n = 21) ACDC-2017 (n = 150) | Validation: auto vs manual Metrics: DICE |
Backhaus, 2019 [212] | LV + RV | Evaluation of SuiteHEART software (Neosoft) 300 randomly selected patients used for validation Single center 1.5 T and 3 T data | Validation: auto vs manual LV: EDV, ESV, SV, EF, LV mass RV: EDV, ESV, EF |
Bhuva, 2019 [197] | LV | Training data: 599 subjects Test data 110 patients, 5 disease categories: myocardial infarction (n = 32), LVH (n = 17), cardiomyopathy (n = 17), other pathology (n = 14), healthy volunteers (n = 30) Multi-center, multi-vendor, 1.5 T + 3 T Scan-rescan data Data availability: | Validation based on comparing scan-rescan reproducibility of automated vs manual analysis EDV, ESV, SV, EF, LV mass Detectable change in EF |
Curiale, 2019 [199] | LV | MICCAI-2009 (n = 45) Cardiac Atlas Project (n = 95) | Validation: auto vs manual Metrics: DICE EDV, ESV, EF, LV mass |
Tong, 2019 [202] | LV + RV | ACDC-2017 (n = 150) | Validation: auto vs manual Metrics: Dice, HD LV: EDV, ESV, EF, LV mass RV: EDV, ESV, EF |